Intricacies of TGF-β signaling in Treg and Th17 cell biology.

Gordon KJ, Blobe GC. Role of transforming growth factor-β superfamily signaling pathways in human disease. Biochimica et Biophysica Acta (BBA) - Mol Basis Dis. 2008;1782:197–228. https://doi.org/10.1016/j.bbadis.2008.01.006

doi: 10.1016/j.bbadis.2008.01.006

Poniatowski ŁA, Wojdasiewicz P, Gasik R, Szukiewicz D. Transforming growth factor Beta family: insight into the role of growth factors in regulation of fracture healing biology and potential clinical applications. Mediators Inflamm. 2015;2015:137823. https://doi.org/10.1155/2015/137823

doi: 10.1155/2015/137823 pubmed: 25709154 pmcid: 4325469

Zhang Y, Alexander PB, Wang XF. TGF-β Family signaling in the control of cell proliferation and survival. Cold Spring Harb Perspect Biol. 9, https://doi.org/10.1101/cshperspect.a022145 (2017).

Wu MY, Hill CS. TGF-β superfamily signaling in embryonic development and homeostasis. Dev Cell. 2009;16:329–43. https://doi.org/10.1016/j.devcel.2009.02.012

doi: 10.1016/j.devcel.2009.02.012 pubmed: 19289080

Xu X, Zheng L, Yuan Q, Zhen G, Crane JL, Zhou X, et al. Transforming growth factor-β in stem cells and tissue homeostasis. Bone Res. 2018;6:2. https://doi.org/10.1038/s41413-017-0005-4

doi: 10.1038/s41413-017-0005-4 pubmed: 29423331 pmcid: 5802812

Sanjabi S, Oh SA, Li MO. Regulation of the immune response by TGF-β: from conception to autoimmunity and infection. Cold Spring Harb Perspect Biol. 9, https://doi.org/10.1101/cshperspect.a022236 . (2017).

Batlle E, Massagué J. Transforming growth factor-β signaling in immunity and cancer. Immunity. 2019;50:924–40.

doi: 10.1016/j.immuni.2019.03.024 pubmed: 30995507 pmcid: 7507121

Morianos I, Papadopoulou G, Semitekolou M, Xanthou G. Activin-A in the regulation of immunity in health and disease. J Autoimmun. 2019;104:102314. https://doi.org/10.1016/j.jaut.2019.102314

doi: 10.1016/j.jaut.2019.102314 pubmed: 31416681

Robson NC, Phillips DJ, McAlpine T, Shin A, Svobodova S, Toy T, et al. Activin-A: a novel dendritic cell–derived cytokine that potently attenuates CD40 ligand–specific cytokine and chemokine production. Blood. 2008;111:2733–43. https://doi.org/10.1182/blood-2007-03-080994

doi: 10.1182/blood-2007-03-080994 pubmed: 18156495

Jones KL, et al. Activin A is a critical component of the inflammatory response, and its binding protein, follistatin, reduces mortality in endotoxemia. Proc Natl Acad Sci. 2007;104:16239–44. https://doi.org/10.1073/pnas.0705971104

doi: 10.1073/pnas.0705971104 pubmed: 17911255 pmcid: 2042191

Ogawa K, Funaba M, Chen Y, Tsujimoto M. Activin A functions as a Th2 cytokine in the promotion of the alternative activation of macrophages1. J Immunol. 2006;177:6787–94. https://doi.org/10.4049/jimmunol.177.10.6787

doi: 10.4049/jimmunol.177.10.6787 pubmed: 17082592

Cortez MA, Masrorpour F, Ivan C, Zhang J, Younes AI, Lu Y, et al. Bone morphogenetic protein 7 promotes resistance to immunotherapy. Nat Commun. 2020;11:4840. https://doi.org/10.1038/s41467-020-18617-z

doi: 10.1038/s41467-020-18617-z pubmed: 32973129 pmcid: 7519103

Zhong S, Li H, Wang YS, Wang Y, Ji G, Li HY, et al. Bmp8a is a novel player in regulation of antiviral immunity. bioRxiv, 2020.2008.2009.243519, https://doi.org/10.1101/2020.08.09.243519 (2020).

Miyazono K, Kamiya Y, Morikawa M. Bone morphogenetic protein receptors and signal transduction. J Biochem. 2009;147:35–51. https://doi.org/10.1093/jb/mvp148

doi: 10.1093/jb/mvp148 pubmed: 19762341

Kersten C, Sivertsen EA, Hystad ME, Forfang L, Smeland EB, Myklebust JH. BMP-6 inhibits growth of mature human B cells; induction of Smad phosphorylation and upregulation of Id1. BMC Immunol. 2005;6:9. https://doi.org/10.1186/1471-2172-6-9

doi: 10.1186/1471-2172-6-9 pubmed: 15877825 pmcid: 1134658

Martínez VG, Hernández-López C, Valencia J, Hidalgo L, Entrena A, Zapata AG, et al. The canonical BMP signaling pathway is involved in human monocyte-derived dendritic cell maturation. Immunol Cell Biol. 2011;89:610–8. https://doi.org/10.1038/icb.2010.135

doi: 10.1038/icb.2010.135 pubmed: 21102536

Yoshioka Y, Ono M, Osaki M, Konishi I, Sakaguchi S. Differential effects of inhibition of bone morphogenic protein (BMP) signalling on T-cell activation and differentiation. Eur J Immunol. 2012;42:749–59. https://doi.org/10.1002/eji.201141702

doi: 10.1002/eji.201141702 pubmed: 22144105

Sanford LP, Ormsby I, Gittenberger-de Groot AC, Sariola H, Friedman R, Boivin GP, et al. TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development. 1997;124:2659–70.

doi: 10.1242/dev.124.13.2659 pubmed: 9217007

Proetzel G, Pawlowski SA, Wiles MV, Yin M, Boivin GP, Howles PN, et al. Transforming growth factor–β3 is required for secondary palate fusion. Nat Genet. 1995;11:409–14.

doi: 10.1038/ng1295-409 pubmed: 7493021

Dickson MC, Martin JS, Cousins FM, Kulkarni AB, Karlsson S, Akhurst RJ. Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Development. 1995;121:1845–54. https://doi.org/10.1242/dev.121.6.1845

doi: 10.1242/dev.121.6.1845 pubmed: 7600998

Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature. 1992;359:693–9. https://doi.org/10.1038/359693a0

doi: 10.1038/359693a0 pubmed: 1436033 pmcid: 3889166

Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, Flanders KC, et al. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci. 1993;90:770–4.

doi: 10.1073/pnas.90.2.770 pubmed: 8421714 pmcid: 45747

Christ M, McCartney-Francis NL, Kulkarni AB, Ward JM, Mizel DE, Mackall CL, et al. Immune dysregulation in TGF-beta 1-deficient mice. J Immunol. 1994;153:1936–46. https://doi.org/10.4049/jimmunol.153.5.1936

doi: 10.4049/jimmunol.153.5.1936 pubmed: 8051399

Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA. Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol. 2006;24:99–146. https://doi.org/10.1146/annurev.immunol.24.021605.090737

doi: 10.1146/annurev.immunol.24.021605.090737 pubmed: 16551245

Ueshima E, Fujimori M, Kodama H, Felsen D, Chen J, Durack JC, et al. Macrophage-secreted TGF-β(1) contributes to fibroblast activation and ureteral stricture after ablation injury. Am J Physiol Ren Physiol. 2019;317:F52–f64. https://doi.org/10.1152/ajprenal.00260.2018

doi: 10.1152/ajprenal.00260.2018

Wynn TA, Barron L. Macrophages: master regulators of inflammation and fibrosis. Semin Liver Dis. 2010;30:245–57. https://doi.org/10.1055/s-0030-1255354

doi: 10.1055/s-0030-1255354 pubmed: 20665377 pmcid: 2924662

Gong D, Shi W, Yi SJ, Chen H, Groffen J, Heisterkamp N. TGFβ signaling plays a critical role in promoting alternative macrophage activation. BMC Immunol. 2012;13:31. https://doi.org/10.1186/1471-2172-13-31

doi: 10.1186/1471-2172-13-31 pubmed: 22703233 pmcid: 3406960

Speck S, Lim J, Shelake S, Matka M, Stoddard J, Farr A, et al. TGF-β signaling initiated in dendritic cells instructs suppressive effects on Th17 differentiation at the site of neuroinflammation. PLOS ONE. 2014;9:e102390. https://doi.org/10.1371/journal.pone.0102390

doi: 10.1371/journal.pone.0102390 pubmed: 25072375 pmcid: 4114567

Lukas D, et al. TGF-β inhibitor Smad7 regulates dendritic cell-induced autoimmunity. Proc Natl Acad Sci. 2017;114:E1480–E1489. https://doi.org/10.1073/pnas.1615065114

doi: 10.1073/pnas.1615065114 pubmed: 28167776 pmcid: 5338403

Bobr A, Igyarto BZ, Haley KM, Li MO, Flavell RA, Kaplan DH. Autocrine/paracrine TGF-β1 inhibits Langerhans cell migration. Proc Natl Acad Sci USA. 2012;109:10492–7. https://doi.org/10.1073/pnas.1119178109

doi: 10.1073/pnas.1119178109 pubmed: 22689996 pmcid: 3387113

Cazac BB, Roes J. TGF-β receptor controls B cell responsiveness and induction of IgA in vivo. Immunity. 2000;13:443–51. https://doi.org/10.1016/S1074-7613(00)00044-3

doi: 10.1016/S1074-7613(00)00044-3 pubmed: 11070163

Bjarnadóttir K, Benkhoucha M, Merkler D, Weber MS, Payne NL, Bernard C, et al. B cell-derived transforming growth factor-β1 expression limits the induction phase of autoimmune neuroinflammation. Sci Rep. 2016;6:34594. https://doi.org/10.1038/srep34594

doi: 10.1038/srep34594 pubmed: 27708418 pmcid: 5052622

Liu Y, Zhang P, Li J, Kulkarni AB, Perruche S, Chen W. A critical function for TGF-β signaling in the development of natural CD4 + CD25+Foxp3+ regulatory T cells. Nat Immunol. 2008;9:632–40. https://doi.org/10.1038/ni.1607

doi: 10.1038/ni.1607 pubmed: 18438410

Marie JC, Liggitt D, Rudensky AY. Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-β receptor. Immunity. 2006;25:441–54. https://doi.org/10.1016/j.immuni.2006.07.012

doi: 10.1016/j.immuni.2006.07.012 pubmed: 16973387

Li MO, Sanjabi S, Flavell RA. Transforming growth factor-β controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and-independent mechanisms. Immunity. 2006;25:455–71.

doi: 10.1016/j.immuni.2006.07.011 pubmed: 16973386

Miyazono K, Olofsson A, Colosetti P, Heldin C-H. A role of the latent TGF‐beta 1‐binding protein in the assembly and secretion of TGF‐beta 1. EMBO J. 1991;10:1091–101.

doi: 10.1002/j.1460-2075.1991.tb08049.x pubmed: 2022183 pmcid: 452762

Derynck R, Budi EH. Specificity, versatility, and control of TGF-beta family signaling. Sci Signal. 2019;12:eaav5183. https://doi.org/10.1126/scisignal.aav5183

doi: 10.1126/scisignal.aav5183 pubmed: 30808818 pmcid: 6800142

Wang R, Zhu J, Dong X, Shi M, Lu C, Springer TA. GARP regulates the bioavailability and activation of TGFβ. Mol Biol Cell. 2012;23:1129–39. https://doi.org/10.1091/mbc.e11-12-1018

doi: 10.1091/mbc.e11-12-1018 pubmed: 22278742 pmcid: 3302739

Robertson IB, Rifkin DB. Regulation of the bioavailability of TGF-beta and TGF-beta-related proteins. Cold Spring Harb Perspect Biol. 8, https://doi.org/10.1101/cshperspect.a021907 (2016).

Schmierer B, Hill CS. TGFβ–SMAD signal transduction: molecular specificity and functional flexibility. Nat Rev Mol Cell Biol. 2007;8:970–82. https://doi.org/10.1038/nrm2297

doi: 10.1038/nrm2297 pubmed: 18000526

Wrighton KH, Lin X, Feng X-H. Phospho-control of TGF-β superfamily signaling. Cell Res. 2009;19:8–20. https://doi.org/10.1038/cr.2008.327

doi: 10.1038/cr.2008.327 pubmed: 19114991

Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature. 2003;425:577–84. https://doi.org/10.1038/nature02006

doi: 10.1038/nature02006 pubmed: 14534577

Wu G, Chen YG, Ozdamar B, Gyuricza CA, Chong PA, Wrana JL, et al. Structural basis of Smad2 recognition by the Smad anchor for receptor activation. Science. 2000;287:92–97. https://doi.org/10.1126/science.287.5450.92

doi: 10.1126/science.287.5450.92 pubmed: 10615055

Tang WB, Ling GH, Sun L, Liu FY. Smad anchor for receptor activation (SARA) in TGF-beta signaling. Front Biosci (Elite Ed). 2010;2:857–60. https://doi.org/10.2741/e147

doi: 10.2741/e147 pubmed: 20515759

He W, Dorn DC, Erdjument-Bromage H, Tempst P, Moore MA, Massagué J. Hematopoiesis controlled by distinct TIF1γ and Smad4 branches of the TGFβ pathway. Cell. 2006;125:929–41. https://doi.org/10.1016/j.cell.2006.03.045

doi: 10.1016/j.cell.2006.03.045 pubmed: 16751102

Goumans MJ, Valdimarsdottir G, Itoh S, Rosendahl A, Sideras P, ten Dijke P. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO J. 2002;21:1743–53. https://doi.org/10.1093/emboj/21.7.1743

doi: 10.1093/emboj/21.7.1743 pubmed: 11927558 pmcid: 125949

Ramachandran A, Vizán P, Das D, Chakravarty P, Vogt J, Rogers KW, et al. TGF-beta uses a novel mode of receptor activation to phosphorylate SMAD1/5 and induce epithelial-to-mesenchymal transition. Elife. 7, https://doi.org/10.7554/eLife.31756 (2018).

Attisano L, Wrana JL. Signal transduction by the TGF-beta superfamily. Science. 2002;296:1646–7. https://doi.org/10.1126/science.1071809

doi: 10.1126/science.1071809 pubmed: 12040180

Zhang Y, Feng XH, Derynck R. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription. Nature. 1998;394:909–13. https://doi.org/10.1038/29814

doi: 10.1038/29814 pubmed: 9732876

Nishita M, Hashimoto MK, Ogata S, Laurent MN, Ueno N, Shibuya H, et al. Interaction between Wnt and TGF-β signalling pathways during formation of Spemann’s organizer. Nature. 2000;403:781–5. https://doi.org/10.1038/35001602

doi: 10.1038/35001602 pubmed: 10693808

Blokzijl A, Dahlqvist C, Reissmann E, Falk A, Moliner A, Lendahl U, et al. Cross-talk between the Notch and TGF-β signaling pathways mediated by interaction of the Notch intracellular domain with Smad3. J Cell Biol. 2003;163:723–8. https://doi.org/10.1083/jcb.200305112

doi: 10.1083/jcb.200305112 pubmed: 14638857 pmcid: 2173673

Nye MD, Almada LL, Fernandez-Barrena MG, Marks DL, Elsawa SF, Vrabel A, et al. The transcription factor GLI1 interacts with SMAD proteins to modulate transforming growth factor β-induced gene expression in a p300/CREB-binding protein-associated factor (PCAF)-dependent manner *. J Biol Chem. 2014;289:15495–506. https://doi.org/10.1074/jbc.M113.545194

doi: 10.1074/jbc.M113.545194 pubmed: 24739390 pmcid: 4140905

Xu P, Lin X, Feng X-H. Posttranslational regulation of Smads. Cold Spring Harb Perspect Biol. 2016;8:a022087.

doi: 10.1101/cshperspect.a022087 pubmed: 27908935 pmcid: 5131773

Wrighton KH, Feng X-H. To (TGF)β or not to (TGF)β: Fine-tuning of Smad signaling via post-translational modifications. Cell Signal. 2008;20:1579–91. https://doi.org/10.1016/j.cellsig.2008.02.003

doi: 10.1016/j.cellsig.2008.02.003 pubmed: 18387785 pmcid: 2597537

Mori S, Matsuzaki K, Yoshida K, Furukawa F, Tahashi Y, Yamagata H, et al. TGF-β and HGF transmit the signals through JNK-dependent Smad2/3 phosphorylation at the linker regions. Oncogene. 2004;23:7416–29. https://doi.org/10.1038/sj.onc.1207981

doi: 10.1038/sj.onc.1207981 pubmed: 15326485

Lin X, Duan X, Liang YY, Su Y, Wrighton KH, Long J, et al. PPM1A functions as a Smad phosphatase to terminate TGFbeta signaling. Cell. 2006;125:915–28. https://doi.org/10.1016/j.cell.2006.03.044

doi: 10.1016/j.cell.2006.03.044 pubmed: 16751101 pmcid: 6309366

Guo X, Waddell DS, Wang W, Wang Z, Liberati NT, Yong S, et al. Ligand-dependent ubiquitination of Smad3 is regulated by casein kinase 1 gamma 2, an inhibitor of TGF-beta signaling. Oncogene. 2008;27:7235–47. https://doi.org/10.1038/onc.2008.337

doi: 10.1038/onc.2008.337 pubmed: 18794808 pmcid: 2643063

Kamaraju AK, Roberts AB. Role of Rho/ROCK and p38 MAP kinase pathways in transforming growth factor-beta-mediated Smad-dependent growth inhibition of human breast carcinoma cells in vivo. J Biol Chem. 2005;280:1024–36. https://doi.org/10.1074/jbc.M403960200

doi: 10.1074/jbc.M403960200 pubmed: 15520018

Mori S, Matsuzaki K, Yoshida K, Furukawa F, Tahashi Y, Yamagata H, et al. TGF-beta and HGF transmit the signals through JNK-dependent Smad2/3 phosphorylation at the linker regions. Oncogene. 2004;23:7416–29. https://doi.org/10.1038/sj.onc.1207981

doi: 10.1038/sj.onc.1207981 pubmed: 15326485

Waddell DS, Liberati NT, Guo X, Frederick JP, Wang XF. Casein kinase Iepsilon plays a functional role in the transforming growth factor-beta signaling pathway. J Biol Chem. 2004;279:29236–46. https://doi.org/10.1074/jbc.M400880200

doi: 10.1074/jbc.M400880200 pubmed: 15133026

Zhu H, Kavsak P, Abdollah S, Wrana JL, Thomsen GH. A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature. 1999;400:687–93. https://doi.org/10.1038/23293

doi: 10.1038/23293 pubmed: 10458166

Zhang Y, Chang C, Gehling DJ, Hemmati-Brivanlou A, Derynck R. Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase. Proc Natl Acad Sci. 2001;98:974–9. https://doi.org/10.1073/pnas.98.3.974

doi: 10.1073/pnas.98.3.974 pubmed: 11158580 pmcid: 14694

Fukuchi M, Imamura T, Chiba T, Ebisawa T, Kawabata M, Tanaka K, et al. Ligand-dependent degradation of Smad3 by a ubiquitin ligase complex of ROC1 and associated proteins. Mol Biol Cell. 2001;12:1431–43. https://doi.org/10.1091/mbc.12.5.1431

doi: 10.1091/mbc.12.5.1431 pubmed: 11359933 pmcid: 34595

Ray D, et al. Transforming growth factor β facilitates β-TrCP-mediated degradation of Cdc25A in a Smad3-dependent manner. Mol Cell Biol. 2005;25:3338–47. https://doi.org/10.1128/MCB.25.8.3338-3347.2005

doi: 10.1128/MCB.25.8.3338-3347.2005 pubmed: 15798217 pmcid: 1069597

Xin H, Xu X, Li L, Ning H, Rong Y, Shang Y, et al. CHIP controls the sensitivity of transforming growth factor-β signaling by modulating the basal level of Smad3 through ubiquitin-mediated degradation. J Biol Chem. 2005;280:20842–50.

doi: 10.1074/jbc.M412275200 pubmed: 15781469

Nagano Y, Mavrakis KJ, Lee KL, Fujii T, Koinuma D, Sase H, et al. Arkadia induces degradation of SnoN and c-Ski to enhance transforming growth factor-β signaling. J Biol Chem. 2007;282:20492–501.

doi: 10.1074/jbc.M701294200 pubmed: 17510063

Levy L, Howell M, Das D, Harkin S, Episkopou V, Hill CS. Arkadia activates Smad3/Smad4-dependent transcription by triggering signal-induced SnoN degradation. Mol Cell Biol. 2007;27:6068–83.

doi: 10.1128/MCB.00664-07 pubmed: 17591695 pmcid: 1952153

Bai Y, Yang C, Hu K, Elly C, Liu Y-C. Itch E3 ligase-mediated regulation of TGF-β signaling by modulating Smad2 phosphorylation. Mol Cell. 2004;15:825–31. https://doi.org/10.1016/j.molcel.2004.07.021

doi: 10.1016/j.molcel.2004.07.021 pubmed: 15350225

Huang Y-T, Cheng AC, Tang HC, Huang GC, Cai L, Lin TH, et al. USP7 facilitates SMAD3 autoregulation to repress cancer progression in p53-deficient lung cancer. Cell Death Dis. 2021;12:880. https://doi.org/10.1038/s41419-021-04176-8

doi: 10.1038/s41419-021-04176-8 pubmed: 34580281 pmcid: 8476631

Bai J, Xi Q. Crosstalk between TGF-β signaling and epigenome. Acta Biochimica et Biophysica Sin. 2017;50:60–67. https://doi.org/10.1093/abbs/gmx122

doi: 10.1093/abbs/gmx122

Xi Q, He W, Zhang XH-F, Le H-V, Massagué J. Genome-wide impact of the BRG1 SWI/SNF chromatin remodeler on the transforming growth factor β transcriptional program. J Biol Chem. 2008;283:1146–55.

doi: 10.1074/jbc.M707479200 pubmed: 18003620

Gaarenstroom T, Hill CS. TGF-β signaling to chromatin: How Smads regulate transcription during self-renewal and differentiation. Semin Cell Dev Biol. 2014;32:107–18. https://doi.org/10.1016/j.semcdb.2014.01.009

doi: 10.1016/j.semcdb.2014.01.009 pubmed: 24503509

Shioda T, Lechleider RJ, Dunwoodie SL, Li H, Yahata T, de Caestecker MP, et al. Transcriptional activating activity of Smad4: roles of SMAD hetero-oligomerization and enhancement by an associating transactivator. Proc Natl Acad Sci. 1998;95:9785–90.

doi: 10.1073/pnas.95.17.9785 pubmed: 9707553 pmcid: 21414

Kim DW, Lassar AB. Smad-dependent recruitment of a histone deacetylase/Sin3A complex modulates the bone morphogenetic protein-dependent transcriptional repressor activity of Nkx3.2. Mol Cell Biol. 2003;23:8704–17. https://doi.org/10.1128/mcb.23.23.8704-8717.2003

doi: 10.1128/mcb.23.23.8704-8717.2003 pubmed: 14612411 pmcid: 262671

Tang X, Li G, Su F, Cai Y, Shi L, Meng Y, et al. HDAC8 cooperates with SMAD3/4 complex to suppress SIRT7 and promote cell survival and migration. Nucleic Acids Res. 2020;48:2912–23. https://doi.org/10.1093/nar/gkaa039

doi: 10.1093/nar/gkaa039 pubmed: 31970414 pmcid: 7102950

Dahle Ø, Kumar A, Kuehn MR. Nodal signaling recruits the histone demethylase Jmjd3 to counteract polycomb-mediated repression at target genes. Sci Signal. 2010;3:ra48–ra48.

doi: 10.1126/scisignal.2000841 pubmed: 20571128 pmcid: 6953396

Zhang YE. Non-Smad signaling pathways of the TGF-β family. Cold Spring Harb Perspect Biol. 9, https://doi.org/10.1101/cshperspect.a022129 (2017).

Lee MK, Pardoux C, Hall MC, Lee PS, Warburton D, Qing J, et al. TGF-beta activates Erk MAP kinase signalling through direct phosphorylation of ShcA. EMBO J. 2007;26:3957–67. https://doi.org/10.1038/sj.emboj.7601818

doi: 10.1038/sj.emboj.7601818 pubmed: 17673906 pmcid: 1994119

Yi JY, Shin I, Arteaga CL. Type I transforming growth factor beta; receptor binds to and activates phosphatidylinositol 3-kinase. J Biol Chem. 2005;280:10870–6. https://doi.org/10.1074/jbc.M413223200

doi: 10.1074/jbc.M413223200 pubmed: 15657037

Hamidi A, et al. TGF-beta promotes PI3K-AKT signaling and prostate cancer cell migration through the TRAF6-mediated ubiquitylation of p85. Sci Signal. 2017;10:eaal4186. https://doi.org/10.1126/scisignal.aal4186

doi: 10.1126/scisignal.aal4186 pubmed: 28676490

Fruman DA, Chiu H, Hopkins BD, Bagrodia S, Cantley LC, Abraham RT. The PI3K pathway in human disease. Cell. 2017;170:605–35. https://doi.org/10.1016/j.cell.2017.07.029

doi: 10.1016/j.cell.2017.07.029 pubmed: 28802037 pmcid: 5726441

Saxton RA, Sabatini DM. mTOR signaling in growth, metabolism, and disease. Cell. 2017;168:960–76.

doi: 10.1016/j.cell.2017.02.004 pubmed: 28283069 pmcid: 5394987

Silverstein AM. Autoimmunity versus horror autotoxicus: the struggle for recognition. Nat Immunol. 2001;2:279–81.

doi: 10.1038/86280 pubmed: 11276193

Taylor A, Verhagen J, Blaser K, Akdis M, Akdis CA. Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells. Immunology. 2006;117:433–42. https://doi.org/10.1111/j.1365-2567.2006.02321.x

doi: 10.1111/j.1365-2567.2006.02321.x pubmed: 16556256 pmcid: 1782242

Schietinger A, Greenberg PD. Tolerance and exhaustion: defining mechanisms of T cell dysfunction. Trends Immunol. 2014;35:51–60. https://doi.org/10.1016/j.it.2013.10.001

doi: 10.1016/j.it.2013.10.001 pubmed: 24210163

Xing Y, Hogquist KA. T-cell tolerance: central and peripheral. Cold Spring Harb Perspect Biol. 4, https://doi.org/10.1101/cshperspect.a006957 (2012).

Klinker MW, Lundy SK. Multiple mechanisms of immune suppression by B lymphocytes. Mol Med. 2012;18:123–37. https://doi.org/10.2119/molmed.2011.00333

doi: 10.2119/molmed.2011.00333 pubmed: 22033729

Fudenberg HH. Genetically determined immune deficiency as the predisposing cause of “auto-immunity” and lymphoid neoplasia. J Immunol. 1971;107:937–937.

doi: 10.4049/jimmunol.107.3.937

Cunningham AJ. Active suppressor mechanism maintaining tolerance to some self components. Nature. 1975;254:143–4. https://doi.org/10.1038/254143a0

doi: 10.1038/254143a0 pubmed: 1090844

Allison AC, Denman AM, Barnes RD. Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity. Lancet. 1971;2:135–40. https://doi.org/10.1016/s0140-6736(71)92306-3

doi: 10.1016/s0140-6736(71)92306-3 pubmed: 4105624

Sakaguchi S, Fukuma K, Kuribayashi K, Masuda T. Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease. J Exp Med. 1985;161:72–87. https://doi.org/10.1084/jem.161.1.72

doi: 10.1084/jem.161.1.72 pubmed: 3871469

Sakaguchi S, Takahashi T, Nishizuka Y. Study on cellular events in post-thymectomy autoimmune oophoritis in mice. II. Requirement of Lyt-1 cells in normal female mice for the prevention of oophoritis. J Exp Med. 1982;156:1577–86. https://doi.org/10.1084/jem.156.6.1577

doi: 10.1084/jem.156.6.1577 pubmed: 6983558

Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995;155:1151–64.

doi: 10.4049/jimmunol.155.3.1151 pubmed: 7636184

Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA, et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet. 2001;27:68–73. https://doi.org/10.1038/83784

doi: 10.1038/83784 pubmed: 11138001

Owen CJ, Jennings CE, Imrie H, Lachaux A, Bridges NA, Cheetham TD, et al. Mutational analysis of the FOXP3 gene and evidence for genetic heterogeneity in the immunodysregulation, polyendocrinopathy, enteropathy syndrome. J Clin Endocrinol Metab. 2003;88:6034–9. https://doi.org/10.1210/jc.2003-031080

doi: 10.1210/jc.2003-031080 pubmed: 14671208

Kobayashi I, Shiari R, Yamada M, Kawamura N, Okano M, Yara A, et al. Novel mutations of FOXP3 in two Japanese patients with immune dysregulation, polyendocrinopathy, enteropathy, X linked syndrome (IPEX). J Med Genet. 2001;38:874–6. https://doi.org/10.1136/jmg.38.12.874

doi: 10.1136/jmg.38.12.874 pubmed: 11768393 pmcid: 1734795

Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet. 2001;27:20–21. https://doi.org/10.1038/83713

doi: 10.1038/83713 pubmed: 11137993

Khattri R, Cox T, Yasayko SA, Ramsdell F. An essential role for Scurfin in CD4 + CD25 + T regulatory cells. Nat Immunol. 2003;4:337–42. https://doi.org/10.1038/ni909

doi: 10.1038/ni909 pubmed: 12612581

Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057–61. https://doi.org/10.1126/science.10794901079490 . [pii]

doi: 10.1126/science.10794901079490 pubmed: 12522256

Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4 + CD25+ regulatory T cells. Nat Immunol. 2003;4:330–6.

doi: 10.1038/ni904 pubmed: 12612578

Corthay A. How do regulatory T cells work? Scand J Immunol. 2009;70:326–36. https://doi.org/10.1111/j.1365-3083.2009.02308.x

doi: 10.1111/j.1365-3083.2009.02308.x pubmed: 19751267 pmcid: 2784904

Akimova T, Hancock WW. How little is known about the role of human FOXP3+ Tregs in tumors. Expert Opin Ther Targets. 2018;22:655–8. https://doi.org/10.1080/14728222.2018.1499728

doi: 10.1080/14728222.2018.1499728 pubmed: 29989842 pmcid: 6294964

Ziegler SF. FOXP3: of mice and men. Annu Rev Immunol. 2006;24:209–26. https://doi.org/10.1146/annurev.immunol.24.021605.090547

doi: 10.1146/annurev.immunol.24.021605.090547 pubmed: 16551248

Abbas AK, Benoist C, Bluestone JA, Campbell DJ, Ghosh S, Hori S, et al. Regulatory T cells: recommendations to simplify the nomenclature. Nat Immunol. 2013;14:307–8. https://doi.org/10.1038/ni.2554

doi: 10.1038/ni.2554 pubmed: 23507634

Shevach EM, Thornton AM. tTregs, pTregs, and iTregs: similarities and differences. Immunol Rev. 2014;259:88–102. https://doi.org/10.1111/imr.12160

doi: 10.1111/imr.12160 pubmed: 24712461 pmcid: 3982187

Burchill MA, Yang J, Vang KB, Moon JJ, Chu HH, Lio CW, et al. Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire. Immunity. 2008;28:112–21. https://doi.org/10.1016/j.immuni.2007.11.022

doi: 10.1016/j.immuni.2007.11.022 pubmed: 18199418 pmcid: 2430111

Hemmers S, Schizas M, Azizi E, Dikiy S, Zhong Y, Feng Y, et al. IL-2 production by self-reactive CD4 thymocytes scales regulatory T cell generation in the thymus. J Exp Med. 2019;216:2466–78. https://doi.org/10.1084/jem.20190993

doi: 10.1084/jem.20190993 pubmed: 31434685 pmcid: 6829602

Lio CW, Hsieh CS. A two-step process for thymic regulatory T cell development. Immunity. 2008;28:100–11. https://doi.org/10.1016/j.immuni.2007.11.021

doi: 10.1016/j.immuni.2007.11.021 pubmed: 18199417 pmcid: 2248212

Josefowicz SZ, Lu LF, Rudensky AY. Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol. 2012;30:531–64. https://doi.org/10.1146/annurev.immunol.25.022106.141623

doi: 10.1146/annurev.immunol.25.022106.141623 pubmed: 22224781 pmcid: 6066374

Morikawa H, Sakaguchi S. Genetic and epigenetic basis of Treg cell development and function: from a FoxP3-centered view to an epigenome-defined view of natural Treg cells. Immunol Rev. 2014;259:192–205. https://doi.org/10.1111/imr.12174

doi: 10.1111/imr.12174 pubmed: 24712467

Joetham A, Schedel M, O'Connor BP, Kim S, Takeda K, Abbott J, et al. Inducible and naturally occurring regulatory T cells enhance lung allergic responses through divergent transcriptional pathways. J Allergy Clin Immunol. 2017;139:1331–42. https://doi.org/10.1016/j.jaci.2016.06.051

doi: 10.1016/j.jaci.2016.06.051 pubmed: 27542981

Josefowicz SZ, Niec RE, Kim HY, Treuting P, Chinen T, Zheng Y, et al. Extrathymically generated regulatory T cells control mucosal TH2 inflammation. Nature. 2012;482:395–9. https://doi.org/10.1038/nature10772

doi: 10.1038/nature10772 pubmed: 22318520 pmcid: 3485072

Curotto de Lafaille MA, Lafaille JJ. Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor? Immunity. 2009;30:626–35. https://doi.org/10.1016/j.immuni.2009.05.002

doi: 10.1016/j.immuni.2009.05.002 pubmed: 19464985

Apostolou I, von Boehmer H. In vivo instruction of suppressor commitment in naive T cells. J Exp Med. 2004;199:1401–8. https://doi.org/10.1084/jem.20040249

doi: 10.1084/jem.20040249 pubmed: 15148338 pmcid: 2211808

Cobbold SP, Castejon R, Adams E, Zelenika D, Graca L, Humm S, et al. Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants. J Immunol. 2004;172:6003–10. https://doi.org/10.4049/jimmunol.172.10.6003

doi: 10.4049/jimmunol.172.10.6003 pubmed: 15128783

Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol. 2005;6:1219–27. https://doi.org/10.1038/ni1265

doi: 10.1038/ni1265 pubmed: 16244650

Mucida D, Kutchukhidze N, Erazo A, Russo M, Lafaille JJ, Curotto de Lafaille MA. Oral tolerance in the absence of naturally occurring Tregs. J Clin Invest. 2005;115:1923–33. https://doi.org/10.1172/JCI24487

doi: 10.1172/JCI24487 pubmed: 15937545 pmcid: 1142115

Chai JN, Peng Y, Rengarajan S, Solomon BD, Ai TL, Shen Z, et al. Helicobacter species are potent drivers of colonic T cell responses in homeostasis and inflammation. Sci Immunol. 2, https://doi.org/10.1126/sciimmunol.aal5068 (2017).

Xu M, Pokrovskii M, Ding Y, Yi R, Au C, Harrison OJ, et al. c-MAF-dependent regulatory T cells mediate immunological tolerance to a gut pathobiont. Nature. 2018;554:373–7. https://doi.org/10.1038/nature25500

doi: 10.1038/nature25500 pubmed: 29414937 pmcid: 5814346

Benson MJ, Pino-Lagos K, Rosemblatt M, Noelle RJ. All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J Exp Med. 2007;204:1765–74. https://doi.org/10.1084/jem.20070719

doi: 10.1084/jem.20070719 pubmed: 17620363 pmcid: 2118687

Coombes JL, Siddiqui KR, Arancibia-Cárcamo CV, Hall J, Sun CM, Belkaid Y, et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med. 2007;204:1757–64. https://doi.org/10.1084/jem.20070590

doi: 10.1084/jem.20070590 pubmed: 17620361 pmcid: 2118683

Mucida D, Park Y, Kim G, Turovskaya O, Scott I, Kronenberg M, et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science. 2007;317:256–60. https://doi.org/10.1126/science.1145697

doi: 10.1126/science.1145697 pubmed: 17569825

Schambach F, Schupp M, Lazar MA, Reiner SL. Activation of retinoic acid receptor-alpha favours regulatory T cell induction at the expense of IL-17-secreting T helper cell differentiation. Eur J Immunol. 2007;37:2396–9. https://doi.org/10.1002/eji.200737621

doi: 10.1002/eji.200737621 pubmed: 17694576

Sun CM, Hall JA, Blank RB, Bouladoux N, Oukka M, Mora JR, et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med. 2007;204:1775–85. https://doi.org/10.1084/jem.20070602

doi: 10.1084/jem.20070602 pubmed: 17620362 pmcid: 2118682

Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly-Y M, et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science. 2013;341:569–73. https://doi.org/10.1126/science.1241165

doi: 10.1126/science.1241165 pubmed: 23828891

Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013;504:446–50. https://doi.org/10.1038/nature12721

doi: 10.1038/nature12721 pubmed: 24226770

Hang S, Paik D, Yao L, Kim E, Trinath J, Lu J, et al. Bile acid metabolites control TH17 and Treg cell differentiation. Nature. 2019;576:143–8. https://doi.org/10.1038/s41586-019-1785-z

doi: 10.1038/s41586-019-1785-z pubmed: 31776512 pmcid: 6949019

Song X, Sun X, Oh SF, Wu M, Zhang Y, Zheng W, et al. Microbial bile acid metabolites modulate gut RORgamma(+) regulatory T cell homeostasis. Nature. 2020;577:410–5. https://doi.org/10.1038/s41586-019-1865-0

doi: 10.1038/s41586-019-1865-0 pubmed: 31875848

Quintana FJ, Basso AS, Iglesias AH, Korn T, Farez MF, Bettelli E, et al. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature. 2008;453:65–71. https://doi.org/10.1038/nature06880

doi: 10.1038/nature06880 pubmed: 18362915

Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, et al. Conversion of peripheral CD4 + CD25- naive T cells to CD4 + CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med. 2003;198:1875–86. https://doi.org/10.1084/jem.20030152

doi: 10.1084/jem.20030152 pubmed: 14676299 pmcid: 2194145

Zheng SG, Wang J, Wang P, Gray JD, Horwitz DA. IL-2 is essential for TGF-beta to convert naive CD4 + CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells. J Immunol. 2007;178:2018–27. https://doi.org/10.4049/jimmunol.178.4.2018

doi: 10.4049/jimmunol.178.4.2018 pubmed: 17277105

Wan YY, Flavell RA. Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc Natl Acad Sci. 2005;102:5126–31. https://doi.org/10.1073/pnas.0501701102

doi: 10.1073/pnas.0501701102 pubmed: 15795373 pmcid: 556008

Floess S, Freyer J, Siewert C, Baron U, Olek S, Polansky J, et al. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol. 2007;5:e38. https://doi.org/10.1371/journal.pbio.0050038

doi: 10.1371/journal.pbio.0050038 pubmed: 17298177 pmcid: 1783672

Yuan X, Cheng G, Malek TR. The importance of regulatory T-cell heterogeneity in maintaining self-tolerance. Immunol Rev. 2014;259:103–14. https://doi.org/10.1111/imr.12163

doi: 10.1111/imr.12163 pubmed: 24712462 pmcid: 3983566

Feuerer M, Hill JA, Mathis D, Benoist C. Foxp3+ regulatory T cells: differentiation, specification, subphenotypes. Nat Immunol. 2009;10:689–95.

doi: 10.1038/ni.1760 pubmed: 19536194

Kim JM, Rasmussen JP, Rudensky AY. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol. 2007;8:191–7. https://doi.org/10.1038/ni1428

doi: 10.1038/ni1428 pubmed: 17136045

Wan YY, Flavell RA. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature. 2007;445:766–70. https://doi.org/10.1038/nature05479

doi: 10.1038/nature05479 pubmed: 17220876

Williams LM, Rudensky AY. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat Immunol. 2007;8:277–84. https://doi.org/10.1038/ni1437

doi: 10.1038/ni1437 pubmed: 17220892

Gavin MA, Rasmussen JP, Fontenot JD, Vasta V, Manganiello VC, Beavo JA, et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature. 2007;445:771–5.

doi: 10.1038/nature05543 pubmed: 17220874

Wan YY. Regulatory T cells: immune suppression and beyond. Cell Mol Immunol. 2010;7:204–10. https://doi.org/10.1038/cmi.2010.20

doi: 10.1038/cmi.2010.20 pubmed: 20383175 pmcid: 2868372

Lo YC, Lee CF, Powell JD. Insight into the role of mTOR and metabolism in T cells reveals new potential approaches to preventing graft rejection. Curr Opin Organ Transpl. 2014;19:363–71. https://doi.org/10.1097/MOT.0000000000000098

doi: 10.1097/MOT.0000000000000098

Chapman NM, Chi H. mTOR signaling, Tregs and immune modulation. Immunotherapy. 2014;6:1295–311. https://doi.org/10.2217/imt.14.84

doi: 10.2217/imt.14.84 pubmed: 25524385

Kerdiles YM, Stone EL, Beisner DR, McGargill MA, Ch'en IL, Stockmann C, et al. Foxo transcription factors control regulatory T cell development and function. Immunity. 2010;33:890–904. https://doi.org/10.1016/j.immuni.2010.12.002

doi: 10.1016/j.immuni.2010.12.002 pubmed: 21167754 pmcid: 3034255

Merkenschlager M, von Boehmer H. PI3 kinase signalling blocks Foxp3 expression by sequestering Foxo factors. J Exp Med. 2010;207:1347–50. https://doi.org/10.1084/jem.20101156

doi: 10.1084/jem.20101156 pubmed: 20603315 pmcid: 2901062

Ouyang W, Beckett O, Ma Q, Paik JH, DePinho RA, Li MO. Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells. Nat Immunol. 2010;11:618–27. https://doi.org/10.1038/ni.1884

doi: 10.1038/ni.1884 pubmed: 20467422

Zheng Y, Josefowicz S, Chaudhry A, Peng XP, Forbush K, Rudensky AY. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature. 2010;463:808–12. https://doi.org/10.1038/nature08750

doi: 10.1038/nature08750 pubmed: 20072126 pmcid: 2884187

Basu R, Hatton RD, Weaver CT. The Th17 family: flexibility follows function. Immunol Rev. 2013;252:89–103. https://doi.org/10.1111/imr.12035

doi: 10.1111/imr.12035 pubmed: 23405897 pmcid: 3607325

Kitoh A, Ono M, Naoe Y, Ohkura N, Yamaguchi T, Yaguchi H, et al. Indispensable role of the Runx1-Cbfbeta transcription complex for in vivo-suppressive function of FoxP3+ regulatory T cells. Immunity. 2009;31:609–20. https://doi.org/10.1016/j.immuni.2009.09.003

doi: 10.1016/j.immuni.2009.09.003 pubmed: 19800266

Wang Y, Su MA, Wan YY. An essential role of the transcription factor GATA-3 for the function of regulatory T cells. Immunity. 2011;35:337–48. https://doi.org/10.1016/j.immuni.2011.08.012

doi: 10.1016/j.immuni.2011.08.012 pubmed: 21924928 pmcid: 3182399

Deng G, Song X, Fujimoto S, Piccirillo CA, Nagai Y, Greene MI. Foxp3 post-translational modifications and Treg suppressive activity. Front Immunol. 2019;10:2486. https://doi.org/10.3389/fimmu.2019.02486

doi: 10.3389/fimmu.2019.02486 pubmed: 31681337 pmcid: 6813729

Li Z, Li D, Tsun A, Li B. FOXP3+ regulatory T cells and their functional regulation. Cell Mol Immunol. 2015;12:558–65. https://doi.org/10.1038/cmi.2015.10

doi: 10.1038/cmi.2015.10 pubmed: 25683611 pmcid: 4579651

Chou WC, Guo Z, Guo H, Chen L, Zhang G, Liang K, et al. AIM2 in regulatory T cells restrains autoimmune diseases. Nature. 2021;591:300–5. https://doi.org/10.1038/s41586-021-03231-w

doi: 10.1038/s41586-021-03231-w pubmed: 33505023 pmcid: 8080937

Shrestha S, Yang K, Guy C, Vogel P, Neale G, Chi H. Treg cells require the phosphatase PTEN to restrain TH1 and TFH cell responses. Nat Immunol. 2015;16:178–87. https://doi.org/10.1038/ni.3076

doi: 10.1038/ni.3076 pubmed: 25559258 pmcid: 4297581

Huynh A, DuPage M, Priyadharshini B, Sage PT, Quiros J, Borges CM, et al. Control of PI(3) kinase in Treg cells maintains homeostasis and lineage stability. Nat Immunol. 2015;16:188–96. https://doi.org/10.1038/ni.3077

doi: 10.1038/ni.3077 pubmed: 25559257 pmcid: 4297515

Luo CT, Liao W, Dadi S, Toure A, Li MO. Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity. Nature. 2016;529:532–6. https://doi.org/10.1038/nature16486

doi: 10.1038/nature16486 pubmed: 26789248 pmcid: 4978705

Wei J, Long L, Yang K, Guy C, Shrestha S, Chen Z, et al. Autophagy enforces functional integrity of regulatory T cells by coupling environmental cues and metabolic homeostasis. Nat Immunol. 2016;17:277–85. https://doi.org/10.1038/ni.3365

doi: 10.1038/ni.3365 pubmed: 26808230 pmcid: 4755832

Miyao T, Floess S, Setoguchi R, Luche H, Fehling HJ, Waldmann H, et al. Plasticity of Foxp3(+) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells. Immunity. 2012;36:262–75. https://doi.org/10.1016/j.immuni.2011.12.012

doi: 10.1016/j.immuni.2011.12.012 pubmed: 22326580

Hori S. Lineage stability and phenotypic plasticity of Foxp3(+) regulatory T cells. Immunol Rev. 2014;259:159–72. https://doi.org/10.1111/imr.12175

doi: 10.1111/imr.12175 pubmed: 24712465

Zhang Z, Zhou X. Foxp3 instability helps ttregs distinguish self and non-self. Front Immunol. 2019;10:2226. https://doi.org/10.3389/fimmu.2019.02226

doi: 10.3389/fimmu.2019.02226 pubmed: 31608056 pmcid: 6769115

Murai M, Krause P, Cheroutre H, Kronenberg M. Regulatory T-cell stability and plasticity in mucosal and systemic immune systems. Mucosal Immunol. 2010;3:443–9. https://doi.org/10.1038/mi.2010.27

doi: 10.1038/mi.2010.27 pubmed: 20505662 pmcid: 2924438

Lu L, Barbi J, Pan F. The regulation of immune tolerance by FOXP3. Nat Rev Immunol. 2017;17:703–17. https://doi.org/10.1038/nri.2017.75

doi: 10.1038/nri.2017.75 pubmed: 28757603 pmcid: 5793224

Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol. 2008;8:523–32. https://doi.org/10.1038/nri2343

doi: 10.1038/nri2343 pubmed: 18566595 pmcid: 2665249

Spolski R, Li P, Leonard WJ. Biology and regulation of IL-2: from molecular mechanisms to human therapy. Nat Rev Immunol. 2018;18:648–59. https://doi.org/10.1038/s41577-018-0046-y

doi: 10.1038/s41577-018-0046-y pubmed: 30089912

Ross SH, Cantrell DA. Signaling and function of interleukin-2 in T lymphocytes. Annu Rev Immunol. 2018;36:411–33. https://doi.org/10.1146/annurev-immunol-042617-053352

doi: 10.1146/annurev-immunol-042617-053352 pubmed: 29677473 pmcid: 6472684

Oderup C, Cederbom L, Makowska A, Cilio CM, Ivars F. Cytotoxic T lymphocyte antigen-4-dependent down-modulation of costimulatory molecules on dendritic cells in CD4 + CD25+ regulatory T-cell-mediated suppression. Immunology. 2006;118:240–9. https://doi.org/10.1111/j.1365-2567.2006.02362.x

doi: 10.1111/j.1365-2567.2006.02362.x pubmed: 16771859 pmcid: 1782280

Cederbom L, Hall H, Ivars F. CD4 + CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur J Immunol. 2000;30:1538–43. https://doi.org/10.1002/1521-4141(200006)30:6<1538::AID-IMMU1538>3.0.CO;2-X

doi: 10.1002/1521-4141(200006)30:6<1538::AID-IMMU1538>3.0.CO;2-X pubmed: 10898488

Sojka DK, Huang YH, Fowell DJ. Mechanisms of regulatory T-cell suppression - a diverse arsenal for a moving target. Immunology. 2008;124:13–22. https://doi.org/10.1111/j.1365-2567.2008.02813.x

doi: 10.1111/j.1365-2567.2008.02813.x pubmed: 18346152 pmcid: 2434375

Cao X, Cai SF, Fehniger TA, Song J, Collins LI, Piwnica-Worms DR, et al. Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance. Immunity. 2007;27:635–46. https://doi.org/10.1016/j.immuni.2007.08.014

doi: 10.1016/j.immuni.2007.08.014 pubmed: 17919943

Jang JE, Hajdu CH, Liot C, Miller G, Dustin ML, Bar-Sagi D. Crosstalk between regulatory T cells and tumor-associated dendritic cells negates anti-tumor immunity in pancreatic cancer. Cell Rep. 2017;20:558–71. https://doi.org/10.1016/j.celrep.2017.06.062

doi: 10.1016/j.celrep.2017.06.062 pubmed: 28723561 pmcid: 5649374

Onishi Y, Fehervari Z, Yamaguchi T, Sakaguchi S. Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc Natl Acad Sci USA. 2008;105:10113–8. https://doi.org/10.1073/pnas.0711106105

doi: 10.1073/pnas.0711106105 pubmed: 18635688 pmcid: 2481354

Angelin A, Gil-de-Gómez L, Dahiya S, Jiao J, Guo L, Levine MH, et al. Foxp3 reprograms T cell metabolism to function in low-glucose, high-lactate environments. Cell Metab. 2017;25:1282–193:e1287. https://doi.org/10.1016/j.cmet.2016.12.018

doi: 10.1016/j.cmet.2016.12.018 pubmed: 28416194 pmcid: 5462872

Li X, Yang Y, Zhang B, Lin X, Fu X, An Y, et al. Lactate metabolism in human health and disease. Signal Transduct Target Ther. 2022;7:305. https://doi.org/10.1038/s41392-022-01151-3

doi: 10.1038/s41392-022-01151-3 pubmed: 36050306 pmcid: 9434547

Pucino V, Certo M, Bulusu V, Cucchi D, Goldmann K, Pontarini E, et al. Lactate buildup at the site of chronic inflammation promotes disease by inducing CD4(+) T cell metab rewiring. Cell Metab. 2019;30:1055–1074:e1058. https://doi.org/10.1016/j.cmet.2019.10.004

doi: 10.1016/j.cmet.2019.10.004 pubmed: 31708446 pmcid: 6899510

Bromley SK, Mempel TR, Luster AD. Orchestrating the orchestrators: chemokines in control of T cell traffic. Nat Immunol. 2008;9:970–80. https://doi.org/10.1038/ni.f.213

doi: 10.1038/ni.f.213 pubmed: 18711434

Iellem A, Mariani M, Lang R, Recalde H, Panina-Bordignon P, Sinigaglia F, et al. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J Exp Med. 2001;194:847–53. https://doi.org/10.1084/jem.194.6.847

doi: 10.1084/jem.194.6.847 pubmed: 11560999 pmcid: 2195967

Chen D, Bromberg JS. T regulatory cells and migration. Am J Transpl. 2006;6:1518–23. https://doi.org/10.1111/j.1600-6143.2006.01372.x

doi: 10.1111/j.1600-6143.2006.01372.x

Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell. 2000;100:655–69. https://doi.org/10.1016/s0092-8674(00)80702-3

doi: 10.1016/s0092-8674(00)80702-3 pubmed: 10761931

Koch MA, Thomas KR, Perdue NR, Smigiel KS, Srivastava S, Campbell DJ. T-bet(+) Treg cells undergo abortive Th1 cell differentiation due to impaired expression of IL-12 receptor beta2. Immunity. 2012;37:501–10. https://doi.org/10.1016/j.immuni.2012.05.031

doi: 10.1016/j.immuni.2012.05.031 pubmed: 22960221 pmcid: 3501343

Honma K, Kimura D, Tominaga N, Miyakoda M, Matsuyama T, Yui K. Interferon regulatory factor 4 differentially regulates the production of Th2 cytokines in naive vs. effector/memory CD4+T cells. Proc Natl Acad Sci USA. 2008;105:15890–5. https://doi.org/10.1073/pnas.0803171105

doi: 10.1073/pnas.0803171105 pubmed: 18836070 pmcid: 2572975

Zheng Y, Chaudhry A, Kas A, deRoos P, Kim JM, Chu TT, et al. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature. 2009;458:351–6. https://doi.org/10.1038/nature07674

doi: 10.1038/nature07674 pubmed: 19182775 pmcid: 2864791

Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17 + T helper. cells Cell. 2006;126:1121–33. https://doi.org/10.1016/j.cell.2006.07.035

doi: 10.1016/j.cell.2006.07.035 pubmed: 16990136

Yang BH, Hagemann S, Mamareli P, Lauer U, Hoffmann U, Beckstette M, et al. Foxp3(+) T cells expressing RORgammat represent a stable regulatory T-cell effector lineage with enhanced suppressive capacity during intestinal inflammation. Mucosal Immunol. 2016;9:444–57. https://doi.org/10.1038/mi.2015.74

doi: 10.1038/mi.2015.74 pubmed: 26307665

Wei G, et al. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4 + T cells. Immunity. 2009;30:155–67. https://doi.org/10.1016/j.immuni.2008.12.009 .

doi: 10.1016/j.immuni.2008.12.009 pubmed: 19144320 pmcid: 2722509

Ohkura N, Sakaguchi S. Transcriptional and epigenetic basis of Treg cell development and function: its genetic anomalies or variations in autoimmune diseases. Cell Res. 2020;30:465–74. https://doi.org/10.1038/s41422-020-0324-7

doi: 10.1038/s41422-020-0324-7 pubmed: 32367041 pmcid: 7264322

Ohnmacht C. ToLerance To The Intestinal Microbiota Mediated by ROR(gammat)(+) Cells. Trends Immunol. 2016;37:477–86. https://doi.org/10.1016/j.it.2016.05.002

doi: 10.1016/j.it.2016.05.002 pubmed: 27255270

van der Veeken J, Campbell C, Pritykin Y, Schizas M, Verter J, Hu W, et al. Genetic tracing reveals transcription factor Foxp3-dependent and Foxp3-independent functionality of peripherally induced Treg cells. Immunity. 2022;55:1173–1184:e1177. https://doi.org/10.1016/j.immuni.2022.05.010

doi: 10.1016/j.immuni.2022.05.010 pubmed: 35700740 pmcid: 9885886

Li J, Tan J, Martino MM, Lui KO. Regulatory T-cells: potential regulator of tissue repair and regeneration. Front Immunol. 2018;9:585. https://doi.org/10.3389/fimmu.2018.00585

doi: 10.3389/fimmu.2018.00585 pubmed: 29662491 pmcid: 5890151

Burzyn D, Benoist C, Mathis D. Regulatory T cells in nonlymphoid tissues. Nat Immunol. 2013;14:1007–13. https://doi.org/10.1038/ni.2683

doi: 10.1038/ni.2683 pubmed: 24048122 pmcid: 4708287

Yamazaki T, Yang XO, Chung Y, Fukunaga A, Nurieva R, Pappu B, et al. CCR6 regulates the migration of inflammatory and regulatory T cells. J Immunol. 2008;181:8391–401. https://doi.org/10.4049/jimmunol.181.12.8391

doi: 10.4049/jimmunol.181.12.8391 pubmed: 19050256

Turner JE, Paust HJ, Steinmetz OM, Peters A, Riedel JH, Erhardt A, et al. CCR6 recruits regulatory T cells and Th17 cells to the kidney in glomerulonephritis. J Am Soc Nephrol. 2010;21:974–85. https://doi.org/10.1681/ASN.2009070741

doi: 10.1681/ASN.2009070741 pubmed: 20299360 pmcid: 2900961

Cook KW, Letley DP, Ingram RJ, Staples E, Skjoldmose H, Atherton JC, et al. CCL20/CCR6-mediated migration of regulatory T cells to the Helicobacter pylori-infected human gastric mucosa. Gut. 2014;63:1550–9. https://doi.org/10.1136/gutjnl-2013-306253

doi: 10.1136/gutjnl-2013-306253 pubmed: 24436142

Burzyn D, Kuswanto W, Kolodin D, Shadrach JL, Cerletti M, Jang Y, et al. A special population of regulatory T cells potentiates muscle repair. Cell. 2013;155:1282–95. https://doi.org/10.1016/j.cell.2013.10.054

doi: 10.1016/j.cell.2013.10.054 pubmed: 24315098 pmcid: 3894749

Castiglioni A, Corna G, Rigamonti E, Basso V, Vezzoli M, Monno A, et al. FOXP3 + T cells recruited to sites of sterile skeletal muscle injury regulate the fate of satellite cells and guide effective tissue regeneration. PLoS One. 2015;10:e0128094. https://doi.org/10.1371/journal.pone.0128094

doi: 10.1371/journal.pone.0128094 pubmed: 26039259 pmcid: 4454513

Arpaia N, Green JA, Moltedo B, Arvey A, Hemmers S, Yuan S, et al. A distinct function of regulatory T cells in tissue protection. Cell. 2015;162:1078–89. https://doi.org/10.1016/j.cell.2015.08.021

doi: 10.1016/j.cell.2015.08.021 pubmed: 26317471 pmcid: 4603556

Dombrowski Y, O'Hagan T, Dittmer M, Penalva R, Mayoral SR, Bankhead P, et al. Regulatory T cells promote myelin regeneration in the central nervous system. Nat Neurosci. 2017;20:674–80. https://doi.org/10.1038/nn.4528

doi: 10.1038/nn.4528 pubmed: 28288125 pmcid: 5409501

de la Vega Gallardo N, Dittmer M, Dombrowski Y, Fitzgerald DC. Regenerating CNS myelin: Emerging roles of regulatory T cells and CCN proteins. Neurochem Int. 2019;130:104349. https://doi.org/10.1016/j.neuint.2018.11.024

doi: 10.1016/j.neuint.2018.11.024 pubmed: 30513363

Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, Fehervari Z, et al. Foxp3 + CD25 + CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev. 2006;212:8–27. https://doi.org/10.1111/j.0105-2896.2006.00427.x

doi: 10.1111/j.0105-2896.2006.00427.x pubmed: 16903903

Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell. 2008;133:775–87. https://doi.org/10.1016/j.cell.2008.05.009

doi: 10.1016/j.cell.2008.05.009 pubmed: 18510923

Alroqi FJ, Chatila TA. T regulatory cell biology in health and disease. Curr Allergy Asthma Rep. 2016;16:27. https://doi.org/10.1007/s11882-016-0606-9

doi: 10.1007/s11882-016-0606-9 pubmed: 26922942 pmcid: 5218767

Hartemann A, Bensimon G, Payan CA, Jacqueminet S, Bourron O, Nicolas N, et al. Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 2013;1:295–305. https://doi.org/10.1016/S2213-8587(13)70113-X

doi: 10.1016/S2213-8587(13)70113-X pubmed: 24622415

Zhou P. Emerging mechanisms and applications of low-dose IL-2 therapy in autoimmunity. Cytokine Growth Factor Rev. 2022;67:80–88. https://doi.org/10.1016/j.cytogfr.2022.06.003

doi: 10.1016/j.cytogfr.2022.06.003 pubmed: 35803833

Kasagi S, Zhang P, Che L, Abbatiello B, Maruyama T, Nakatsukasa H, et al. In vivo-generated antigen-specific regulatory T cells treat autoimmunity without compromising antibacterial immune response. Sci Transl Med. 2014;6:241ra278. https://doi.org/10.1126/scitranslmed.3008895

doi: 10.1126/scitranslmed.3008895

Selck C, Dominguez-Villar M. Antigen-specific regulatory T cell therapy in autoimmune diseases and transplantation. Front Immunol. 2021;12:661875. https://doi.org/10.3389/fimmu.2021.661875

doi: 10.3389/fimmu.2021.661875 pubmed: 34054826 pmcid: 8160309

Sarmay G. Biologia Futura: Emerging antigen-specific therapies for autoimmune diseases. Biol Futur. 2021;72:15–24. https://doi.org/10.1007/s42977-021-00074-4

doi: 10.1007/s42977-021-00074-4 pubmed: 34554499

Gorantla VS, Schneeberger S, Brandacher G, Sucher R, Zhang D, Lee WP, et al. T regulatory cells and transplantation tolerance. Transpl Rev (Orlando). 2010;24:147–59. https://doi.org/10.1016/j.trre.2010.04.002

doi: 10.1016/j.trre.2010.04.002

Pilat N, Wiletel M, Weijler AM, Steiner R, Mahr B, Warren J, et al. Treg-mediated prolonged survival of skin allografts without immunosuppression. Proc Natl Acad Sci USA. 2019;116:13508–16. https://doi.org/10.1073/pnas.1903165116

doi: 10.1073/pnas.1903165116 pubmed: 31196957 pmcid: 6613183

Palomares O, Yaman G, Azkur AK, Akkoc T, Akdis M, Akdis CA. Role of Treg in immune regulation of allergic diseases. Eur J Immunol. 2010;40:1232–40. https://doi.org/10.1002/eji.200940045

doi: 10.1002/eji.200940045 pubmed: 20148422

Taylor MD, van der Werf N, Harris A, Graham AL, Bain O, Allen JE, et al. Early recruitment of natural CD4+ Foxp3+ Treg cells by infective larvae determines the outcome of filarial infection. Eur J Immunol. 2009;39:192–206. https://doi.org/10.1002/eji.200838727

doi: 10.1002/eji.200838727 pubmed: 19089814

Oldenhove G, Bouladoux N, Wohlfert EA, Hall JA, Chou D, Dos Santos L, et al. Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity. 2009;31:772–86. https://doi.org/10.1016/j.immuni.2009.10.001

doi: 10.1016/j.immuni.2009.10.001 pubmed: 19896394 pmcid: 2814877

Kulkarni OP, Lichtnekert J, Anders HJ, Mulay SR. the immune system in tissue environments regaining homeostasis after injury: Is “Inflammation” always inflammation? Mediators Inflamm. 2016;2016:2856213. https://doi.org/10.1155/2016/2856213

doi: 10.1155/2016/2856213 pubmed: 27597803 pmcid: 4997018

Belkaid Y, Tarbell K. Regulatory T cells in the control of host-microorganism interactions (*). Annu Rev Immunol. 2009;27:551–89. https://doi.org/10.1146/annurev.immunol.021908.132723 .

doi: 10.1146/annurev.immunol.021908.132723 pubmed: 19302048

Fulop T, Larbi A, Dupuis G, Le Page A, Frost EH, Cohen AA, et al. Immunosenescence and inflamm-aging as two sides of the same coin: friends or foes? Front Immunol. 2017;8:1960. https://doi.org/10.3389/fimmu.2017.01960

doi: 10.3389/fimmu.2017.01960 pubmed: 29375577

Kennedy BK, Berger SL, Brunet A, Campisi J, Cuervo AM, Epel ES, et al. Geroscience: linking aging to chronic disease. Cell. 2014;159:709–13. https://doi.org/10.1016/j.cell.2014.10.039

doi: 10.1016/j.cell.2014.10.039 pubmed: 25417146 pmcid: 4852871

Furman D, Campisi J, Verdin E, Carrera-Bastos P, Targ S, Franceschi C, et al. Chronic inflammation in the etiology of disease across the life span. Nat Med. 2019;25:1822–32. https://doi.org/10.1038/s41591-019-0675-0

doi: 10.1038/s41591-019-0675-0 pubmed: 31806905 pmcid: 7147972

Guo Z, Wang G, Wu B, Chou WC, Cheng L, Zhou C, et al. DCAF1 regulates Treg senescence via the ROS axis during immunological aging. J Clin Invest. 2020;130:5893–908. https://doi.org/10.1172/JCI136466

doi: 10.1172/JCI136466 pubmed: 32730228 pmcid: 7598062

Ha TY. The role of regulatory T cells in cancer. Immune Netw. 2009;9:209–35. https://doi.org/10.4110/in.2009.9.6.209

doi: 10.4110/in.2009.9.6.209 pubmed: 20157609 pmcid: 2816955

Halvorsen EC, Mahmoud SM, Bennewith KL. Emerging roles of regulatory T cells in tumour progression and metastasis. Cancer Metastasis Rev. 2014;33:1025–41. https://doi.org/10.1007/s10555-014-9529-x

doi: 10.1007/s10555-014-9529-x pubmed: 25359584

Fridman WH, Pages F, Sautes-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer. 2012;12:298–306. https://doi.org/10.1038/nrc3245

doi: 10.1038/nrc3245 pubmed: 22419253

Yamaguchi T, Sakaguchi S. Regulatory T cells in immune surveillance and treatment of cancer. Semin Cancer Biol. 2006;16:115–23. https://doi.org/10.1016/j.semcancer.2005.11.005

doi: 10.1016/j.semcancer.2005.11.005 pubmed: 16376102

Ohue Y, Nishikawa H. Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target? Cancer Sci. 2019;110:2080–9. https://doi.org/10.1111/cas.14069

doi: 10.1111/cas.14069 pubmed: 31102428 pmcid: 6609813

Facciabene A, Motz GT, Coukos G. T-regulatory cells: key players in tumor immune escape and angiogenesis. Cancer Res. 2012;72:2162–71. https://doi.org/10.1158/0008-5472.CAN-11-3687

doi: 10.1158/0008-5472.CAN-11-3687 pubmed: 22549946 pmcid: 3342842

Nishikawa H, Kato T, Tanida K, Hiasa A, Tawara I, Ikeda H, et al. CD4 + CD25 + T cells responding to serologically defined autoantigens suppress antitumor immune responses. Proc Natl Acad Sci USA. 2003;100:10902–6. https://doi.org/10.1073/pnas.1834479100

doi: 10.1073/pnas.1834479100 pubmed: 12947044 pmcid: 196900

Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science. 1994;265:1237–40. https://doi.org/10.1126/science.7520605

doi: 10.1126/science.7520605 pubmed: 7520605

Dwarakanath BS, Farooque A, Gupta S. Targeting regulatory T cells for improving cancer therapy: Challenges and prospects. Cancer Rep. (Hoboken). 2018;1:e21105. https://doi.org/10.1002/cnr2.1105

doi: 10.1002/cnr2.1105 pubmed: 32729245

Cinier J, Hubert M, Besson L, Di Roio A, Rodriguez C, Lombardi V, et al. Recruitment and expansion of tregs cells in the tumor environment-how to target them? Cancers (Basel). 13, https://doi.org/10.3390/cancers13081850 (2021).

Chen BJ, Zhao JW, Zhang DH, Zheng AH, Wu GQ. Immunotherapy of cancer by targeting regulatory T cells. Int Immunopharmacol. 2022;104:108469. https://doi.org/10.1016/j.intimp.2021.108469

doi: 10.1016/j.intimp.2021.108469 pubmed: 35008005

Gorelik L, Flavell RA. Transforming growth factor-β in T-cell biology. Nat Rev Immunol. 2002;2:46–53. https://doi.org/10.1038/nri704

doi: 10.1038/nri704 pubmed: 11905837

Tone Y, Furuuchi K, Kojima Y, Tykocinski ML, Greene MI, Tone M. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat Immunol. 2008;9:194–202. https://doi.org/10.1038/ni1549

doi: 10.1038/ni1549 pubmed: 18157133

Fantini MC, Becker C, Monteleone G, Pallone F, Galle PR, Neurath MF. Cutting Edge: TGF-β induces a regulatory phenotype in CD4 + CD25 − T cells through Foxp3 induction and down-regulation of Smad7. J Immunol. 2004;172:5149–53. https://doi.org/10.4049/jimmunol.172.9.5149

doi: 10.4049/jimmunol.172.9.5149 pubmed: 15100250

Hadaschik EN, Enk AH. TGF-β1-induced regulatory T cells. Hum Immunol. 2015;76:561–4. https://doi.org/10.1016/j.humimm.2015.06.015

doi: 10.1016/j.humimm.2015.06.015 pubmed: 26116540

Tu E, Chia C, Chen W, Zhang D, Park SA, Jin W, et al. T cell receptor-regulated TGF-beta type I receptor expression determines T cell quiescence and activation. Immunity. 2018;48:745–759:e746. https://doi.org/10.1016/j.immuni.2018.03.025

doi: 10.1016/j.immuni.2018.03.025 pubmed: 29669252 pmcid: 5911925

Gu A-D, Zhang S, Wang Y, Xiong H, Curtis TA, Wan YY. A critical role for transcription factor Smad4 in T cell function that is independent of transforming growth factor β receptor signaling. Immunity. 2015;42:68–79. https://doi.org/10.1016/j.immuni.2014.12.019

doi: 10.1016/j.immuni.2014.12.019 pubmed: 25577439

Konkel JE, Jin W, Abbatiello B, Grainger JR, Chen W. Thymocyte apoptosis drives the intrathymic generation of regulatory T cells. Proc Natl Acad Sci. 2014;111:E465–E473. https://doi.org/10.1073/pnas.1320319111

doi: 10.1073/pnas.1320319111 pubmed: 24474796 pmcid: 3910656

Ouyang W, Beckett O, Ma Q, Li MO. Transforming growth factor-β signaling curbs thymic negative selection promoting regulatory T cell development. Immunity. 2010;32:642–53. https://doi.org/10.1016/j.immuni.2010.04.012

doi: 10.1016/j.immuni.2010.04.012 pubmed: 20471291 pmcid: 2880228

Ishigame H, Zenewicz LA, Sanjabi S, Licona-Limón P, Nakayama M, Leonard WJ, et al. Excessive Th1 responses due to the absence of TGF-beta signaling cause autoimmune diabetes and dysregulated Treg cell homeostasis. Proc Natl Acad Sci USA. 2013;110:6961–6. https://doi.org/10.1073/pnas.1304498110

doi: 10.1073/pnas.1304498110 pubmed: 23569233 pmcid: 3637710

Zhang N, Bevan MJ. TGF-beta signaling to T cells inhibits autoimmunity during lymphopenia-driven proliferation. Nat Immunol. 2012;13:667–73. https://doi.org/10.1038/ni.2319

doi: 10.1038/ni.2319 pubmed: 22634866 pmcid: 3380154

Konkel JE, Zhang D, Zanvit P, Chia C, Zangarle-Murray T, Jin W, et al. Transforming growth factor-β signaling in regulatory T cells controls T Helper-17 cells and tissue-specific immune responses. Immunity. 2017;46:660–74. https://doi.org/10.1016/j.immuni.2017.03.015

doi: 10.1016/j.immuni.2017.03.015 pubmed: 28423340

Green EA, Gorelik L, McGregor CM, Tran EH, Flavell RA. CD4 + CD25 + T regulatory cells control anti-islet CD8 + T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes. Proc Natl Acad Sci USA. 2003;100:10878–83. https://doi.org/10.1073/pnas.1834400100

doi: 10.1073/pnas.1834400100 pubmed: 12949259 pmcid: 196896

Gutcher I, Donkor MK, Ma Q, Rudensky AY, Flavell RA, Li MO. Autocrine transforming growth factor-beta1 promotes in vivo Th17 cell differentiation. Immunity. 2011;34:396–408. https://doi.org/10.1016/j.immuni.2011.03.005

doi: 10.1016/j.immuni.2011.03.005 pubmed: 21435587 pmcid: 3690311

Li MO, Wan YY, Flavell RA. T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity. 2007;26:579–91. https://doi.org/10.1016/j.immuni.2007.03.014

doi: 10.1016/j.immuni.2007.03.014 pubmed: 17481928

Turner JA, Stephen-Victor E, Wang S, Rivas MN, Abdel-Gadir A, Harb H, et al. Regulatory T cell-derived TGF-beta1 controls multiple checkpoints governing allergy and auto. Immun Immun. 2020;53:1202–1214:e1206. https://doi.org/10.1016/j.immuni.2020.10.002

doi: 10.1016/j.immuni.2020.10.002

Velegraki M, Salem M, Ansa-Addo EA, Wu BX, Li Z. Autocrine transforming growth factor beta1 in regulatory T cell biology-gone but not missed. Immunity. 2021;54:395–6. https://doi.org/10.1016/j.immuni.2021.02.007

doi: 10.1016/j.immuni.2021.02.007 pubmed: 33691126

Marie JC, Letterio JJ, Gavin M, Rudensky AY. TGF-beta1 maintains suppressor function and Foxp3 expression in CD4 + CD25+ regulatory T cells. J Exp Med. 2005;201:1061–7. https://doi.org/10.1084/jem.20042276

doi: 10.1084/jem.20042276 pubmed: 15809351 pmcid: 2213134

Hill JA, Feuerer M, Tash K, Haxhinasto S, Perez J, Melamed R, et al. Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. Immunity. 2007;27:786–800. https://doi.org/10.1016/j.immuni.2007.09.010

doi: 10.1016/j.immuni.2007.09.010 pubmed: 18024188

Selvaraj RK, Geiger TL. A kinetic and dynamic analysis of Foxp3 induced in T cells by TGF-β. J Immunol. 2007;178:7667–77.

doi: 10.4049/jimmunol.178.12.7667 pubmed: 17548603

Martinez GJ, Zhang Z, Chung Y, Reynolds JM, Lin X, Jetten AM, et al. Smad3 differentially regulates the induction of regulatory and inflammatory T cell differentiation *. J Biol Chem. 2009;284:35283–6. https://doi.org/10.1074/jbc.C109.078238

doi: 10.1074/jbc.C109.078238 pubmed: 19887374 pmcid: 2790957

Martinez GJ, Zhang Z, Reynolds JM, Tanaka S, Chung Y, Liu T, et al. Smad2 positively regulates the generation of Th17 cells. J Biol Chem. 2010;285:29039–43. https://doi.org/10.1074/jbc.C110.155820

doi: 10.1074/jbc.C110.155820 pubmed: 20667820 pmcid: 2937933

Gu A-D, Wang Y, Lin L, Zhang SS, Wan YY. Requirements of transcription factor Smad-dependent and -independent TGF-β signaling to control discrete T-cell functions. Proc Natl Acad Sci. 2012;109:905–10. https://doi.org/10.1073/pnas.1108352109

doi: 10.1073/pnas.1108352109 pubmed: 22219364 pmcid: 3271895

Takimoto T, Wakabayashi Y, Sekiya T, Inoue N, Morita R, Ichiyama K, et al. Smad2 and Smad3 are redundantly essential for the TGF-beta-mediated regulation of regulatory T plasticity and Th1 development. J Immunol. 2010;185:842–55. https://doi.org/10.4049/jimmunol.0904100

doi: 10.4049/jimmunol.0904100 pubmed: 20548029

Yang XO, Nurieva R, Martinez GJ, Kang HS, Chung Y, Pappu BP, et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity. 2008;29:44–56. https://doi.org/10.1016/j.immuni.2008.05.007

doi: 10.1016/j.immuni.2008.05.007 pubmed: 18585065 pmcid: 2630532

Xu H, Wu L, Nguyen HH, Mesa KR, Raghavan V, Episkopou V, et al. Arkadia-SKI/SnoN signaling differentially regulates TGF-β–induced iTreg and Th17 cell differentiation. J Exp Med 218, https://doi.org/10.1084/jem.20210777 (2021).

Nakao A, Okumura K, Ogawa H. Smad7: a new key player in TGF-beta-associated disease. Trends Mol Med. 2002;8:361–3. https://doi.org/10.1016/s1471-4914(02)02376-6

doi: 10.1016/s1471-4914(02)02376-6 pubmed: 12127716

Zhang S, Takaku M, Zou L, Gu AD, Chou WC, Zhang G, et al. Reversing SKI-SMAD4-mediated suppression is essential for TH17 cell differentiation. Nature. 2017;551:105–9. https://doi.org/10.1038/nature24283

doi: 10.1038/nature24283 pubmed: 29072299 pmcid: 5743442

Schlenner SM, Weigmann B, Ruan Q, Chen Y, von Boehmer H. Smad3 binding to the foxp3 enhancer is dispensable for the development of regulatory T cells with the exception of the gut. J Exp Med. 2012;209:1529–35. https://doi.org/10.1084/jem.20112646

doi: 10.1084/jem.20112646 pubmed: 22908322 pmcid: 3428940

Chen W, ten Dijke P. Immunoregulation by members of the TGFβ superfamily. Nat Rev Immunol. 2016;16:723–40. https://doi.org/10.1038/nri.2016.112

doi: 10.1038/nri.2016.112 pubmed: 27885276

Huber S, Stahl FR, Schrader J, Lüth S, Presser K, Carambia A, et al. Activin a promotes the TGF-β-induced conversion of CD4 + CD25 − T cells into Foxp3+ induced regulatory T cells. J Immunol. 2009;182:4633–40.

doi: 10.4049/jimmunol.0803143 pubmed: 19342638

Read S, Malmström V, Powrie F. Cytotoxic T lymphocyte–associated antigen 4 plays an essential role in the function of CD25 + CD4+ regulatory cells that control intestinal inflammation. J Exp Med. 2000;192:295–302.

doi: 10.1084/jem.192.2.295 pubmed: 10899916 pmcid: 2193261

Nakamura K, Kitani A, Strober W. Cell contact–dependent immunosuppression by Cd4 + Cd25+regulatory T cells is mediated by cell surface–bound transforming growth factor β. J Exp Med. 2001;194:629–44. https://doi.org/10.1084/jem.194.5.629

doi: 10.1084/jem.194.5.629 pubmed: 11535631 pmcid: 2195935

Barnes MJ, Li CM, Xu Y, An J, Huang Y, Cyster JG. The lysophosphatidylserine receptor GPR174 constrains regulatory T cell development and function. J Exp Med. 2015;212:1011–20. https://doi.org/10.1084/jem.20141827

doi: 10.1084/jem.20141827 pubmed: 26077720 pmcid: 4493414

Zhou Y, Lee JY, Lee CM, Cho WK, Kang MJ, Koff JL, et al. Amphiregulin, an epidermal growth factor receptor ligand, plays an essential role in the pathogenesis of transforming growth factor-beta-induced pulmonary fibrosis. J Biol Chem. 2012;287:41991–42000. https://doi.org/10.1074/jbc.M112.356824

doi: 10.1074/jbc.M112.356824 pubmed: 23086930 pmcid: 3516745

Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 1989;7:145–73. https://doi.org/10.1146/annurev.iy.07.040189.001045

doi: 10.1146/annurev.iy.07.040189.001045 pubmed: 2523712

Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, Hunte B, et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity. 2000;13:715–25. https://doi.org/10.1016/s1074-7613(00)00070-4

doi: 10.1016/s1074-7613(00)00070-4 pubmed: 11114383

Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B, et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature. 2003;421:744–8. https://doi.org/10.1038/nature01355

doi: 10.1038/nature01355 pubmed: 12610626

Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med. 2005;201:233–40. https://doi.org/10.1084/jem.20041257

doi: 10.1084/jem.20041257 pubmed: 15657292 pmcid: 2212798

Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 2005;6:1123–32. https://doi.org/10.1038/ni1254

doi: 10.1038/ni1254 pubmed: 16200070

Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 2005;6:1133–41. https://doi.org/10.1038/ni1261

doi: 10.1038/ni1261 pubmed: 16200068 pmcid: 1618871

Dong C. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol. 2008;8:337–48. https://doi.org/10.1038/nri2295

doi: 10.1038/nri2295 pubmed: 18408735

Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 cells. Annu Rev Immunol. 2009;27:485–517. https://doi.org/10.1146/annurev.immunol.021908.132710

doi: 10.1146/annurev.immunol.021908.132710 pubmed: 19132915

Wu B, Wan Y. Molecular control of pathogenic Th17 cells in autoimmune diseases. Int Immunopharmacol. 2020;80:106187 https://doi.org/10.1016/j.intimp.2020.106187

doi: 10.1016/j.intimp.2020.106187 pubmed: 31931372 pmcid: 7031035

Schnell A, Huang L, Singer M, Singaraju A, Barilla RM, Regan B, et al. Stem-like intestinal Th17 cells give rise to pathogenic effector T cells during autoimmunity. Cell. 2021;184:6281–698:e6223. https://doi.org/10.1016/j.cell.2021.11.018

doi: 10.1016/j.cell.2021.11.018 pubmed: 34875227 pmcid: 8900676

McGeachy MJ, Bak-Jensen KS, Chen Y, Tato CM, Blumenschein W, McClanahan T, et al. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol. 2007;8:1390–97. https://doi.org/10.1038/ni1539

doi: 10.1038/ni1539 pubmed: 17994024

Ghoreschi K, Laurence A, Yang XP, Tato CM, McGeachy MJ, Konkel JE, et al. Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling. Nature. 2010;467:967–71. https://doi.org/10.1038/nature09447

doi: 10.1038/nature09447 pubmed: 20962846 pmcid: 3108066

Wu B, Zhang S, Guo Z, Bi Y, Zhou M, Li P, et al. The TGF-beta superfamily cytokine Activin-A is induced during autoimmune neuroinflammation and drives pathogenic Th17 cell differentiation. Immunity. 2021;54:308–323:e306. https://doi.org/10.1016/j.immuni.2020.12.010

doi: 10.1016/j.immuni.2020.12.010 pubmed: 33421362 pmcid: 7878438

Lee Y, Awasthi A, Yosef N, Quintana FJ, Xiao S, Peters A, et al. Induction and molecular signature of pathogenic TH17 cells. Nat Immunol. 2012;13:991–9. https://doi.org/10.1038/ni.2416

doi: 10.1038/ni.2416 pubmed: 22961052 pmcid: 3459594

Lee YK, Mukasa R, Hatton RD, Weaver CT. Developmental plasticity of Th17 and Treg cells. Curr Opin Immunol. 2009;21:274–80. https://doi.org/10.1016/j.coi.2009.05.021

doi: 10.1016/j.coi.2009.05.021 pubmed: 19524429

Stritesky GL, Yeh N, Kaplan MH. IL-23 promotes maintenance but not commitment to the Th17 lineage. J Immunol. 2008;181:5948–55. https://doi.org/10.4049/jimmunol.181.9.5948

doi: 10.4049/jimmunol.181.9.5948 pubmed: 18941183

Gaublomme JT, Yosef N, Lee Y, Gertner RS, Yang LV, Wu C, et al. Single-cell genomics unveils critical regulators of Th17 cell pathogenicity. Cell. 2015;163:1400–12. https://doi.org/10.1016/j.cell.2015.11.009

doi: 10.1016/j.cell.2015.11.009 pubmed: 26607794 pmcid: 4671824

Wang C, Yosef N, Gaublomme J, Wu C, Lee Y, Clish CB, et al. CD5L/AIM regulates lipid biosynthesis and restrains Th17 cell pathogenicity. Cell. 2015;163:1413–27. https://doi.org/10.1016/j.cell.2015.10.068

doi: 10.1016/j.cell.2015.10.068 pubmed: 26607793 pmcid: 4671820

Zhou L, Lopes JE, Chong MM, Ivanov II, Min R, Victora GD, et al. TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function. Nature. 2008;453:236–40. https://doi.org/10.1038/nature06878

doi: 10.1038/nature06878 pubmed: 18368049 pmcid: 2597437

Zhang F, Meng G, Strober W. Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells. Nat Immunol. 2008;9:1297–306. https://doi.org/10.1038/ni.1663

doi: 10.1038/ni.1663 pubmed: 18849990 pmcid: 4778724

Akira S. Roles of STAT3 defined by tissue-specific gene targeting. Oncogene. 2000;19:2607–11. https://doi.org/10.1038/sj.onc.1203478

doi: 10.1038/sj.onc.1203478 pubmed: 10851059

Korn T, Bettelli E, Gao W, Awasthi A, Jäger A, Strom TB, et al. IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells. Nature. 2007;448:484–7.

doi: 10.1038/nature05970 pubmed: 17581588 pmcid: 3805028

Coquet JM, Chakravarti S, Smyth MJ, Godfrey DI. Cutting edge: IL-21 is not essential for Th17 differentiation or experimental autoimmune encephalomyelitis. J Immunol. 2008;180:7097–101. https://doi.org/10.4049/jimmunol.180.11.7097

doi: 10.4049/jimmunol.180.11.7097 pubmed: 18490706

Sonderegger I, Kisielow J, Meier R, King C, Kopf M. IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo. Eur J Immunol. 2008;38:1833–8. https://doi.org/10.1002/eji.200838511

doi: 10.1002/eji.200838511 pubmed: 18546146

Holmdahl R. IL-21 and autoimmune disease–hypothesis and reality? Eur J Immunol. 2008;38:1800–2. https://doi.org/10.1002/eji.200838529

doi: 10.1002/eji.200838529 pubmed: 18546147

Fina D, Sarra M, Fantini MC, Rizzo A, Caruso R, Caprioli F, et al. Regulation of gut inflammation and th17 cell response by interleukin-21. Gastroenterology. 2008;134:1038–48. https://doi.org/10.1053/j.gastro.2008.01.041

doi: 10.1053/j.gastro.2008.01.041 pubmed: 18395085

Veldhoen M, Hocking RJ, Flavell RA, Stockinger B. Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. Nat Immunol. 2006;7:1151–6. https://doi.org/10.1038/ni1391

doi: 10.1038/ni1391 pubmed: 16998492

Chi X, Jin W, Zhao X, Xie T, Shao J, Bai X, et al. RORgammat expression in mature TH17 cells safeguards their lineage specification by inhibiting conversion to TH2 cells. Sci Adv. 2022;8:eabn7774. https://doi.org/10.1126/sciadv.abn7774

doi: 10.1126/sciadv.abn7774 pubmed: 36026450 pmcid: 9417185

Nurieva R, Yang XO, Martinez G, Zhang Y, Panopoulos AD, Ma L, et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature. 2007;448:480–3. https://doi.org/10.1038/nature05969

doi: 10.1038/nature05969 pubmed: 17581589

Zhou L, Ivanov II, Spolski R, Min R, Shenderov K, Egawa T, et al. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol. 2007;8:967–74. https://doi.org/10.1038/ni1488

doi: 10.1038/ni1488 pubmed: 17581537

Yang XO, Pappu BP, Nurieva R, Akimzhanov A, Kang HS, Chung Y, et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity. 2008;28:29–39. https://doi.org/10.1016/j.immuni.2007.11.016

doi: 10.1016/j.immuni.2007.11.016 pubmed: 18164222

Harris TJ, Grosso JF, Yen HR, Xin H, Kortylewski M, Albesiano E, et al. Cutting edge: An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity. J Immunol. 2007;179:4313–7. https://doi.org/10.4049/jimmunol.179.7.4313

doi: 10.4049/jimmunol.179.7.4313 pubmed: 17878325

Yang XO, Panopoulos AD, Nurieva R, Chang SH, Wang D, Watowich SS, et al. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem. 2007;282:9358–63. https://doi.org/10.1074/jbc.C600321200

doi: 10.1074/jbc.C600321200 pubmed: 17277312

Hall JA, Pokrovskii M, Kroehling L, Kim BR, Kim SY, Wu L, et al. Transcription factor RORalpha enforces stability of the Th17 cell effector program by binding to a Rorc cis-regulatory element. Immunity. 2022;55:2027–2043:e2029. https://doi.org/10.1016/j.immuni.2022.09.013

doi: 10.1016/j.immuni.2022.09.013 pubmed: 36243007 pmcid: 9757081

Akimzhanov AM, Yang XO, Dong C. Chromatin remodeling of interleukin-17 (IL-17)-IL-17F cytokine gene locus during inflammatory helper T cell differentiation. J Biol Chem. 2007;282:5969–72. https://doi.org/10.1074/jbc.C600322200

doi: 10.1074/jbc.C600322200 pubmed: 17218320

Wei L, Laurence A, Elias KM, O’Shea JJ. IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner. J Biol Chem. 2007;282:34605–10. https://doi.org/10.1074/jbc.M705100200

doi: 10.1074/jbc.M705100200 pubmed: 17884812

Chen Z, Laurence A, Kanno Y, Pacher-Zavisin M, Zhu BM, Tato C, et al. Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc Natl Acad Sci USA. 2006;103:8137–42. https://doi.org/10.1073/pnas.0600666103

doi: 10.1073/pnas.0600666103 pubmed: 16698929 pmcid: 1459629

Laurence A, Tato CM, Davidson TS, Kanno Y, Chen Z, Yao Z, et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity. 2007;26:371–81. https://doi.org/10.1016/j.immuni.2007.02.009

doi: 10.1016/j.immuni.2007.02.009 pubmed: 17363300

Lohoff M, Mittrücker HW, Prechtl S, Bischof S, Sommer F, Kock S, et al. Dysregulated T helper cell differentiation in the absence of interferon regulatory factor 4. Proc Natl Acad Sci USA. 2002;99:11808–12. https://doi.org/10.1073/pnas.182425099

doi: 10.1073/pnas.182425099 pubmed: 12189207 pmcid: 129350

Rengarajan J, Mowen KA, McBride KD, Smith ED, Singh H, Glimcher LH. Interferon regulatory factor 4 (IRF4) interacts with NFATc2 to modulate interleukin 4 gene expression. J Exp Med. 2002;195:1003–12. https://doi.org/10.1084/jem.20011128

doi: 10.1084/jem.20011128 pubmed: 11956291 pmcid: 2193700

Hu CM, Jang SY, Fanzo JC, Pernis AB. Modulation of T cell cytokine production by interferon regulatory factor-4. J Biol Chem. 2002;277:49238–46. https://doi.org/10.1074/jbc.M205895200

doi: 10.1074/jbc.M205895200 pubmed: 12374808

Brüstle A, Heink S, Huber M, Rosenplänter C, Stadelmann C, Yu P, et al. The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4. Nat Immunol. 2007;8:958–66. https://doi.org/10.1038/ni1500

doi: 10.1038/ni1500 pubmed: 17676043

Moisan J, Grenningloh R, Bettelli E, Oukka M, Ho IC. Ets-1 is a negative regulator of Th17 differentiation. J Exp Med. 2007;204:2825–35. https://doi.org/10.1084/jem.20070994

doi: 10.1084/jem.20070994 pubmed: 17967903 pmcid: 2118518

Ciofani M, Madar A, Galan C, Sellars M, Mace K, Pauli F, et al. A validated regulatory network for Th17 cell specification. Cell. 2012;151:289–303. https://doi.org/10.1016/j.cell.2012.09.016

doi: 10.1016/j.cell.2012.09.016 pubmed: 23021777 pmcid: 3503487

Rutz S, Noubade R, Eidenschenk C, Ota N, Zeng W, Zheng Y, et al. Transcription factor c-Maf mediates the TGF-beta-dependent suppression of IL-22 production in T(H)17 cells. Nat Immunol. 2011;12:1238–45. https://doi.org/10.1038/ni.2134

doi: 10.1038/ni.2134 pubmed: 22001828

Bauquet AT, Jin H, Paterson AM, Mitsdoerffer M, Ho IC, Sharpe AH, et al. The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells. Nat Immunol. 2009;10:167–75. https://doi.org/10.1038/ni.1690

doi: 10.1038/ni.1690 pubmed: 19098919

Tanaka S, Suto A, Iwamoto T, Kashiwakuma D, Kagami S, Suzuki K, et al. Sox5 and c-Maf cooperatively induce Th17 cell differentiation via RORgammat induction as downstream targets of Stat3. J Exp Med. 2014;211:1857–74. https://doi.org/10.1084/jem.20130791

doi: 10.1084/jem.20130791 pubmed: 25073789 pmcid: 4144730

Minns D, Smith KJ, Alessandrini V, Hardisty G, Melrose L, Jackson-Jones L, et al. The neutrophil antimicrobial peptide cathelicidin promotes Th17 differentiation. Nat Commun. 2021;12:1285. https://doi.org/10.1038/s41467-021-21533-5

doi: 10.1038/s41467-021-21533-5 pubmed: 33627652 pmcid: 7904761

Veldhoen M, Hirota K, Westendorf AM, Buer J, Dumoutier L, Renauld JC, et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature. 2008;453:106–9. https://doi.org/10.1038/nature06881

doi: 10.1038/nature06881 pubmed: 18362914

Dang EV, Barbi J, Yang HY, Jinasena D, Yu H, Zheng Y, et al. Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell. 2011;146:772–84. https://doi.org/10.1016/j.cell.2011.07.033

doi: 10.1016/j.cell.2011.07.033 pubmed: 21871655 pmcid: 3387678

Shi LZ, Wang R, Huang G, Vogel P, Neale G, Green DR, et al. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J Exp Med. 2011;208:1367–76. https://doi.org/10.1084/jem.20110278

doi: 10.1084/jem.20110278 pubmed: 21708926 pmcid: 3135370

Esplugues E, Huber S, Gagliani N, Hauser AE, Town T, Wan YY, et al. Control of TH17 cells occurs in the small intestine. Nature. 2011;475:514–8. https://doi.org/10.1038/nature10228

doi: 10.1038/nature10228 pubmed: 21765430 pmcid: 3148838

Berod L, Friedrich C, Nandan A, Freitag J, Hagemann S, Harmrolfs K, et al. De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells. Nat Med. 2014;20:1327–33. https://doi.org/10.1038/nm.3704

doi: 10.1038/nm.3704 pubmed: 25282359

Chang SH, Chung Y, Dong C. Vitamin D suppresses Th17 cytokine production by inducing C/EBP homologous protein (CHOP) expression. J Biol Chem. 2010;285:38751–5. https://doi.org/10.1074/jbc.C110.185777

doi: 10.1074/jbc.C110.185777 pubmed: 20974859 pmcid: 2998156

Krueger GG, Langley RG, Leonardi C, Yeilding N, Guzzo C, Wang Y, et al. A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. N. Engl J Med. 2007;356:580–92. https://doi.org/10.1056/NEJMoa062382

doi: 10.1056/NEJMoa062382 pubmed: 17287478

Kirkham BW, Lassere MN, Edmonds JP, Juhasz KM, Bird PA, Lee CS. et al. Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (the DAMAGE study cohort). Arthritis Rheum.2006;54:1122–31. https://doi.org/10.1002/art.21749 .

doi: 10.1002/art.21749 pubmed: 16572447

Matusevicius D, Kivisäkk P, He B, Kostulas N, Ozenci V, Fredrikson S, et al. Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult Scler. 1999;5:101–4. https://doi.org/10.1177/135245859900500206

doi: 10.1177/135245859900500206 pubmed: 10335518

Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science. 2006;314:1461–3. https://doi.org/10.1126/science.1135245

doi: 10.1126/science.1135245 pubmed: 17068223 pmcid: 4410764

Molet S, Hamid Q, Davoine F, Nutku E, Taha R, Pagé N, et al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol. 2001;108:430–8. https://doi.org/10.1067/mai.2001.117929

doi: 10.1067/mai.2001.117929 pubmed: 11544464

Barczyk A, Pierzchala W, Sozanska E. Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Respir Med. 2003;97:726–33. https://doi.org/10.1053/rmed.2003.1507

doi: 10.1053/rmed.2003.1507 pubmed: 12814161

Torimoto K, Okada Y, Nakayamada S, Kubo S, Kurozumi A, Narisawa M, et al. Comprehensive immunophenotypic analysis reveals the pathological involvement of Th17 cells in Graves’ disease. Sci Rep. 2022;12:16880. https://doi.org/10.1038/s41598-022-19556-z

doi: 10.1038/s41598-022-19556-z pubmed: 36207336 pmcid: 9546934

Heidt S, Segundo DS, Chadha R, Wood KJ. The impact of Th17 cells on transplant rejection and the induction of tolerance. Curr Opin Organ Transpl. 2010;15:456–61. https://doi.org/10.1097/MOT.0b013e32833b9bfb

doi: 10.1097/MOT.0b013e32833b9bfb

Abadja F, Sarraj B, Ansari MJ. Significance of T helper 17 immunity in transplantation. Curr Opin Organ Transpl. 2012;17:8–14. https://doi.org/10.1097/MOT.0b013e32834ef4e4

doi: 10.1097/MOT.0b013e32834ef4e4

Milner JD, Brenchley JM, Laurence A, Freeman AF, Hill BJ, Elias KM, et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature. 2008;452:773–6. https://doi.org/10.1038/nature06764

doi: 10.1038/nature06764 pubmed: 18337720 pmcid: 2864108

Pène J, Chevalier S, Preisser L, Vénéreau E, Guilleux MH, Ghannam S, et al. Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J Immunol. 2008;180:7423–30. https://doi.org/10.4049/jimmunol.180.11.7423

doi: 10.4049/jimmunol.180.11.7423 pubmed: 18490742

Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S, et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest. 1999;103:1345–52. https://doi.org/10.1172/JCI5703

doi: 10.1172/JCI5703 pubmed: 10225978 pmcid: 408356

Miranda-Carús ME, Benito-Miguel M, Balsa A, Cobo-Ibáñez T, Pérez de Ayala C, Pascual-Salcedo D, et al. Peripheral blood T lymphocytes from patients with early rheumatoid arthritis express RANKL and interleukin-15 on the cell surface and promote osteoclastogenesis in autologous monocytes. Arthritis Rheum. 2006;54:1151–64. https://doi.org/10.1002/art.21731

doi: 10.1002/art.21731 pubmed: 16575870

Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y, et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med. 2006;203:2673–82. https://doi.org/10.1084/jem.20061775

doi: 10.1084/jem.20061775 pubmed: 17088434 pmcid: 2118166

Koenders MI, Lubberts E, van de Loo FA, Oppers-Walgreen B, van den Bersselaar L, Helsen MM, et al. Interleukin-17 acts independently of TNF-alpha under arthritic conditions. J Immunol. 2006;176:6262–9. https://doi.org/10.4049/jimmunol.176.10.6262

doi: 10.4049/jimmunol.176.10.6262 pubmed: 16670337

Koenders MI, Lubberts E, Oppers-Walgreen B, van den Bersselaar L, Helsen MM, Kolls JK, et al. Induction of cartilage damage by overexpression of T cell interleukin-17A in experimental arthritis in mice deficient in interleukin-1. Arthritis Rheum. 2005;52:975–83. https://doi.org/10.1002/art.20885

doi: 10.1002/art.20885 pubmed: 15751058

Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, Garren H, et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med. 2002;8:500–8. https://doi.org/10.1038/nm0502-500

doi: 10.1038/nm0502-500 pubmed: 11984595

Ishizu T, Osoegawa M, Mei FJ, Kikuchi H, Tanaka M, Takakura Y, et al. Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis. Brain. 2005;128:988–1002. https://doi.org/10.1093/brain/awh453

doi: 10.1093/brain/awh453 pubmed: 15743872

Kebir H, Kreymborg K, Ifergan I, Dodelet-Devillers A, Cayrol R, Bernard M, et al. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med. 2007;13:1173–5. https://doi.org/10.1038/nm1651

doi: 10.1038/nm1651 pubmed: 17828272 pmcid: 5114125

Hernandez-Santos N, Gaffen SL. Th17 cells in immunity to Candida albicans. Cell Host Microbe. 2012;11:425–35. https://doi.org/10.1016/j.chom.2012.04.008

doi: 10.1016/j.chom.2012.04.008 pubmed: 22607796 pmcid: 3358697

Ma CS, Chew GY, Simpson N, Priyadarshi A, Wong M, Grimbacher B, et al. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J Exp Med. 2008;205:1551–7. https://doi.org/10.1084/jem.20080218

doi: 10.1084/jem.20080218 pubmed: 18591410 pmcid: 2442632

Conti HR, Gaffen SL. IL-17-mediated immunity to the opportunistic fungal pathogen candida albicans. J Immunol. 2015;195:780–8. https://doi.org/10.4049/jimmunol.1500909

doi: 10.4049/jimmunol.1500909 pubmed: 26188072

Infante-Duarte C, Horton HF, Byrne MC, Kamradt T. Microbial lipopeptides induce the production of IL-17 in Th cells. J Immunol. 2000;165:6107–15. https://doi.org/10.4049/jimmunol.165.11.6107

doi: 10.4049/jimmunol.165.11.6107 pubmed: 11086043

Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, Schwarzenberger P, et al. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med. 2001;194:519–27. https://doi.org/10.1084/jem.194.4.519

doi: 10.1084/jem.194.4.519 pubmed: 11514607 pmcid: 2193502

Chung DR, Kasper DL, Panzo RJ, Chitnis T, Grusby MJ, Sayegh MH, et al. CD4 + T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism. J Immunol. 2003;170:1958–63. https://doi.org/10.4049/jimmunol.170.4.1958

doi: 10.4049/jimmunol.170.4.1958 pubmed: 12574364

Khader SA, Bell GK, Pearl JE, Fountain JJ, Rangel-Moreno J, Cilley GE, et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4 + T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol. 2007;8:369–77. https://doi.org/10.1038/ni1449

doi: 10.1038/ni1449 pubmed: 17351619

Rudner XL, Happel KI, Young EA, Shellito JE. Interleukin-23 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection. Infect Immun. 2007;75:3055–61. https://doi.org/10.1128/IAI.01329-06

doi: 10.1128/IAI.01329-06 pubmed: 17403873 pmcid: 1932856

Huang W, Na L, Fidel PL, Schwarzenberger P. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis. 2004;190:624–31. https://doi.org/10.1086/422329

doi: 10.1086/422329 pubmed: 15243941

Gaffen SL, Hernandez-Santos N, Peterson AC. IL-17 signaling in host defense against Candida albicans. Immunol Res. 2011;50:181–7. https://doi.org/10.1007/s12026-011-8226-x

doi: 10.1007/s12026-011-8226-x pubmed: 21717069 pmcid: 3257840

Romani L. Immunity to fungal infections. Nat Rev Immunol. 2011;11:275–88. https://doi.org/10.1038/nri2939

doi: 10.1038/nri2939 pubmed: 21394104

Ogongo P, Tezera LB, Ardain A, Nhamoyebonde S, Ramsuran D, Singh A, et al. Tissue-resident-like CD4 + T cells secreting IL-17 control Mycobacterium tuberculosis in the human lung. J Clin Invest. 131, https://doi.org/10.1172/JCI142014 (2021).

Acosta-Rodriguez EV, Rivino L, Geginat J, Jarrossay D, Gattorno M, Lanzavecchia A, et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol. 2007;8:639–46. https://doi.org/10.1038/ni1467

doi: 10.1038/ni1467 pubmed: 17486092

Eyerich K, Foerster S, Rombold S, Seidl HP, Behrendt H, Hofmann H, et al. Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22. J Invest Dermatol. 2008;128:2640–5. https://doi.org/10.1038/jid.2008.139

doi: 10.1038/jid.2008.139 pubmed: 18615114

Martonik D, Parfieniuk-Kowerda A, Rogalska, M, Flisiak R. The role of Th17 response in COVID-19. Cells. 10, https://doi.org/10.3390/cells10061550 (2021).

Nathan A, Beynor JI, Baglaenko Y, Suliman S, Ishigaki K, Asgari S, et al. Multimodally profiling memory T cells from a tuberculosis cohort identifies cell state associations with demographics, environment and disease. Nat Immunol. 2021;22:781–93. https://doi.org/10.1038/s41590-021-00933-1

doi: 10.1038/s41590-021-00933-1 pubmed: 34031617 pmcid: 8162307

Gosselin A, Monteiro P, Chomont N, Diaz-Griffero F, Said EA, Fonseca S, et al. Peripheral blood CCR4 + CCR6+ and CXCR3 + CCR6 + CD4 + T cells are highly permissive to HIV-1 infection. J Immunol. 2010;184:1604–16. https://doi.org/10.4049/jimmunol.0903058

doi: 10.4049/jimmunol.0903058 pubmed: 20042588

Dubin PJ, Kolls JK. IL-23 mediates inflammatory responses to mucoid Pseudomonas aeruginosa lung infection in mice. Am J Physiol Lung Cell Mol Physiol. 2007;292:L519–528. https://doi.org/10.1152/ajplung.00312.2006

doi: 10.1152/ajplung.00312.2006 pubmed: 17071720

Romani L, Fallarino F, De Luca A, Montagnoli C, D'Angelo C, Zelante T, et al. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature. 2008;451:211–5. https://doi.org/10.1038/nature06471

doi: 10.1038/nature06471 pubmed: 18185592

Crome SQ, Wang AY, Levings MK. Translational mini-review series on Th17 cells: function and regulation of human T helper 17 cells in health and disease. Clin Exp Immunol. 2010;159:109–19. https://doi.org/10.1111/j.1365-2249.2009.04037.x

doi: 10.1111/j.1365-2249.2009.04037.x pubmed: 19912252 pmcid: 2810379

Mitsdoerffer M, Lee Y, Jäger A, Kim HJ, Korn T, Kolls JK, et al. Proinflammatory T helper type 17 cells are effective B-cell helpers. Proc Natl Acad Sci USA. 2010;107:14292–7. https://doi.org/10.1073/pnas.1009234107

doi: 10.1073/pnas.1009234107 pubmed: 20660725 pmcid: 2922571

Patakas A, Benson RA, Withers DR, Conigliaro P, McInnes IB, Brewer JM, et al. Th17 effector cells support B cell responses outside of germinal centres. PLoS One. 2012;7:e49715 https://doi.org/10.1371/journal.pone.0049715

doi: 10.1371/journal.pone.0049715 pubmed: 23166752 pmcid: 3500323

Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity. 2008;28:454–67. https://doi.org/10.1016/j.immuni.2008.03.004

doi: 10.1016/j.immuni.2008.03.004 pubmed: 18400188 pmcid: 3424508

Ouyang W, O’Garra A. IL-10 family cytokines IL-10 and IL-22: from basic science to clinical translation. Immunity. 2019;50:871–91. https://doi.org/10.1016/j.immuni.2019.03.020

doi: 10.1016/j.immuni.2019.03.020 pubmed: 30995504

Dudakov JA, Hanash AM, van den Brink MR. Interleukin-22: immunobiology and pathology. Annu Rev Immunol. 2015;33:747–85. https://doi.org/10.1146/annurev-immunol-032414-112123

doi: 10.1146/annurev-immunol-032414-112123 pubmed: 25706098 pmcid: 4407497

Hirota K, Yoshitomi H, Hashimoto M, Maeda S, Teradaira S, Sugimoto N, et al. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J Exp Med. 2007;204:2803–12. https://doi.org/10.1084/jem.20071397

doi: 10.1084/jem.20071397 pubmed: 18025126 pmcid: 2118525

Annunziato F, Cosmi L, Santarlasci V, Maggi L, Liotta F, Mazzinghi B, et al. Phenotypic and functional features of human Th17 cells. J Exp Med. 2007;204:1849–61. https://doi.org/10.1084/jem.20070663

doi: 10.1084/jem.20070663 pubmed: 17635957 pmcid: 2118657

Brockmann L, Giannou AD, Gagliani N, Huber S. Regulation of TH17 cells and associated cytokines in wound healing, tissue regeneration, and carcinogenesis. Int J Mol Sci. 18, https://doi.org/10.3390/ijms18051033 (2017).

Zenewicz LA, Yancopoulos GD, Valenzuela DM, Murphy AJ, Karow M, Flavell RA. Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity. 2007;27:647–59. https://doi.org/10.1016/j.immuni.2007.07.023

doi: 10.1016/j.immuni.2007.07.023 pubmed: 17919941 pmcid: 2149911

Zenewicz LA, Yancopoulos GD, Valenzuela DM, Murphy AJ, Stevens S, Flavell RA. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity. 2008;29:947–57. https://doi.org/10.1016/j.immuni.2008.11.003

doi: 10.1016/j.immuni.2008.11.003 pubmed: 19100701 pmcid: 3269819

Wolk K, Witte E, Wallace E, Döcke WD, Kunz S, Asadullah K, et al. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol. 2006;36:1309–23. https://doi.org/10.1002/eji.200535503

doi: 10.1002/eji.200535503 pubmed: 16619290

Rutz S, Eidenschenk C, Ouyang W. IL-22, not simply a Th17 cytokine. Immunol Rev. 2013;252:116–32. https://doi.org/10.1111/imr.12027

doi: 10.1111/imr.12027 pubmed: 23405899

Guglani L, Khader SA. Th17 cytokines in mucosal immunity and inflammation. Curr Opin HIV AIDS. 2010;5:120–7. https://doi.org/10.1097/COH.0b013e328335c2f6

doi: 10.1097/COH.0b013e328335c2f6 pubmed: 20543588 pmcid: 2892849

Blaschitz C, Raffatellu M. Th17 cytokines and the gut mucosal barrier. J Clin Immunol. 2010;30:196–203. https://doi.org/10.1007/s10875-010-9368-7

doi: 10.1007/s10875-010-9368-7 pubmed: 20127275 pmcid: 2842875

Favre D, Lederer S, Kanwar B, Ma ZM, Proll S, Kasakow Z, et al. Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection. PLoS Pathog. 2009;5:e1000295. https://doi.org/10.1371/journal.ppat.1000295

doi: 10.1371/journal.ppat.1000295 pubmed: 19214220 pmcid: 2635016

Pallikkuth S, Micci L, Ende ZS, Iriele RI, Cervasi B, Lawson B, et al. Maintenance of intestinal Th17 cells and reduced microbial translocation in SIV-infected rhesus macaques treated with interleukin (IL)-21. PLoS Pathog. 2013;9:e1003471. https://doi.org/10.1371/journal.ppat.1003471

doi: 10.1371/journal.ppat.1003471 pubmed: 23853592 pmcid: 3701718

Fung TC, Artis D, Sonnenberg GF. Anatomical localization of commensal bacteria in immune cell homeostasis and disease. Immunol Rev. 2014;260:35–49. https://doi.org/10.1111/imr.12186

doi: 10.1111/imr.12186 pubmed: 24942680 pmcid: 4216679

Bixler SL, Mattapallil JJ. Loss and dysregulation of Th17 cells during HIV infection. Clin Dev Immunol. 2013;2013:852418. https://doi.org/10.1155/2013/852418

doi: 10.1155/2013/852418 pubmed: 23762098 pmcid: 3677006

Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006;12:1365–71. https://doi.org/10.1038/nm1511

doi: 10.1038/nm1511 pubmed: 17115046

Charles KA, Kulbe H, Soper R, Escorcio-Correia M, Lawrence T, Schultheis A, et al. The tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans. J Clin Invest. 2009;119:3011–23. https://doi.org/10.1172/JCI39065

doi: 10.1172/JCI39065 pubmed: 19741298 pmcid: 2752076

Derhovanessian E, Adams V, Hähnel K, Groeger A, Pandha H, Ward S, et al. Pretreatment frequency of circulating IL-17 + CD4 + T-cells, but not Tregs, correlates with clinical response to whole-cell vaccination in prostate cancer patients. Int J Cancer. 2009;125:1372–9. https://doi.org/10.1002/ijc.24497

doi: 10.1002/ijc.24497 pubmed: 19533748

Kuang DM, Peng C, Zhao Q, Wu Y, Chen MS, Zheng L. Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells. Hepatology. 2010;51:154–64. https://doi.org/10.1002/hep.23291

doi: 10.1002/hep.23291 pubmed: 19902483

Muranski P, Boni A, Antony PA, Cassard L, Irvine KR, Kaiser A, et al. Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood. 2008;112:362–73. https://doi.org/10.1182/blood-2007-11-120998

doi: 10.1182/blood-2007-11-120998 pubmed: 18354038 pmcid: 2442746

Martin-Orozco N, Muranski P, Chung Y, Yang XO, Yamazaki T, Lu S, et al. T helper 17 cells promote cytotoxic T cell activation in tumor immunity. Immunity. 2009;31:787–98. https://doi.org/10.1016/j.immuni.2009.09.014

doi: 10.1016/j.immuni.2009.09.014 pubmed: 19879162 pmcid: 2787786

Muranski P, Borman ZA, Kerkar SP, Klebanoff CA, Ji Y, Sanchez-Perez L, et al. Th17 cells are long lived and retain a stem cell-like molecular signature. Immunity. 2011;35:972–85. https://doi.org/10.1016/j.immuni.2011.09.019

doi: 10.1016/j.immuni.2011.09.019 pubmed: 22177921 pmcid: 3246082

Luckey CJ, Weaver CT. Stem-cell-like qualities of immune memory; CD4 + T cells join the party. Cell Stem Cell. 2012;10:107–8. https://doi.org/10.1016/j.stem.2012.01.011

doi: 10.1016/j.stem.2012.01.011 pubmed: 22305557 pmcid: 3277283

Hong HS, Mbah NE, Shan M, Loesel K, Lin L, Sajjakulnukit P, et al. OXPHOS promotes apoptotic resistance and cellular persistence in TH17 cells in the periphery and tumor microenvironment. Sci Immunol. 2022;7:eabm8182. https://doi.org/10.1126/sciimmunol.abm8182

doi: 10.1126/sciimmunol.abm8182 pubmed: 36399539 pmcid: 9853437

Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X, Yen HR, et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med. 2009;15:1016–22. https://doi.org/10.1038/nm.2015

doi: 10.1038/nm.2015 pubmed: 19701202 pmcid: 3034219

Zou W, Restifo NP. T(H)17 cells in tumour immunity and immunotherapy. Nat Rev Immunol. 2010;10:248–56. https://doi.org/10.1038/nri2742

doi: 10.1038/nri2742 pubmed: 20336152 pmcid: 3242804

Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 2006;24:179–89. https://doi.org/10.1016/j.immuni.2006.01.001

doi: 10.1016/j.immuni.2006.01.001 pubmed: 16473830

Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441:235–8. https://doi.org/10.1038/nature04753

doi: 10.1038/nature04753 pubmed: 16648838

Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC, Elson CO, et al. Transforming growth factor-β induces development of the TH17 lineage. Nature. 2006;441:231–4. https://doi.org/10.1038/nature04754

doi: 10.1038/nature04754 pubmed: 16648837

Pasare C, Medzhitov R. Toll pathway-dependent blockade of CD4 + CD25 + T cell-mediated suppression by dendritic cells. Science. 2003;299:1033–6. https://doi.org/10.1126/science.1078231

doi: 10.1126/science.1078231 pubmed: 12532024

Qin H, Wang L, Feng T, Elson CO, Niyongere SA, Lee SJ, et al. TGF-β promotes Th17 cell development through inhibition of SOCS3. J Immunol. 2009;183:97–105.

doi: 10.4049/jimmunol.0801986 pubmed: 19535626

Malhotra N, Robertson E, Kang J. SMAD2 is essential for TGF-beta-mediated Th17 cell generation. J Biol Chem. 2010;285:29044–8. https://doi.org/10.1074/jbc.C110.156745

doi: 10.1074/jbc.C110.156745 pubmed: 20656683 pmcid: 2937934

Yoon J-H, Sudo K, Kuroda M, Kato M, Lee IK, Han JS, et al. Phosphorylation status determines the opposing functions of Smad2/Smad3 as STAT3 cofactors in TH17 differentiation. Nat Commun. 2015;6:7600. https://doi.org/10.1038/ncomms8600

doi: 10.1038/ncomms8600 pubmed: 26194464

Tanaka S, Jiang Y, Martinez GJ, Tanaka K, Yan X, Kurosaki T, et al. Trim33 mediates the proinflammatory function of Th17 cells. J Exp Med. 2018;215:1853–68. https://doi.org/10.1084/jem.20170779

doi: 10.1084/jem.20170779 pubmed: 29930104 pmcid: 6028517

Lu L, Wang J, Zhang F, Chai Y, Brand D, Wang X, et al. Role of SMAD and Non-SMAD signals in the development of Th17 and regulatory T cells. J Immunol. 2010;184:4295–306. https://doi.org/10.4049/jimmunol.0903418

doi: 10.4049/jimmunol.0903418 pubmed: 20304828

Chang X, Liu F, Wang X, Lin A, Zhao H, Su B. The kinases MEKK2 and MEKK3 regulate transforming growth factor-beta-mediated helper T cell differentiation. Immunity. 2011;34:201–12. https://doi.org/10.1016/j.immuni.2011.01.017

doi: 10.1016/j.immuni.2011.01.017 pubmed: 21333552 pmcid: 3073014

Hahn JN, Falck VG, Jirik FR. Smad4 deficiency in T cells leads to the Th17-associated development of premalignant gastroduodenal lesions in mice. J Clin Investig. 2011;121:4030–42.

doi: 10.1172/JCI45114 pubmed: 21881210 pmcid: 3195457

Zhang S, Zhang G, Wan YY. SKI and SMAD4 are essential for IL-21-induced Th17 differentiation. Mol Immunol. 2019;114:260–8. https://doi.org/10.1016/j.molimm.2019.07.029

doi: 10.1016/j.molimm.2019.07.029 pubmed: 31398665 pmcid: 6857814

Wang X, Ni L, Wan S, Zhao X, Ding X, Dejean A, et al. Febrile temperature critically controls the differentiation and pathogenicity of T helper 17 cells. Immunity. 2020;52:328–341:e325. https://doi.org/10.1016/j.immuni.2020.01.006

doi: 10.1016/j.immuni.2020.01.006 pubmed: 32049050

Sun Y, Liu X, Eaton EN, Lane WS, Lodish HF, Weinberg RA. Interaction of the ski oncoprotein with Smad3 regulates TGF-β signaling. Mol Cell. 1999;4:499–509. https://doi.org/10.1016/S1097-2765(00)80201-4

doi: 10.1016/S1097-2765(00)80201-4 pubmed: 10549282

Tecalco-Cruz AC, Ríos-López DG, Vázquez-Victorio G, Rosales-Alvarez RE, Macías-Silva M. Transcriptional cofactors Ski and SnoN are major regulators of the TGF-β/Smad signaling pathway in health and disease. Signal Transduct Target Ther. 2018;3:15. https://doi.org/10.1038/s41392-018-0015-8

doi: 10.1038/s41392-018-0015-8 pubmed: 29892481 pmcid: 5992185

Deheuninck J, Luo K. Ski and SnoN, potent negative regulators of TGF-beta signaling. Cell Res. 2009;19:47–57. https://doi.org/10.1038/cr.2008.324

doi: 10.1038/cr.2008.324 pubmed: 19114989

Patel DD, Kuchroo VK. Th17 cell pathway in human immunity: lessons from genetics and therapeutic interventions. Immunity. 2015;43:1040–51.

doi: 10.1016/j.immuni.2015.12.003 pubmed: 26682981

Gaffen SL, Jain R, Garg AV, Cua DJ. The IL-23–IL-17 immune axis: from mechanisms to therapeutic testing. Nat Rev Immunol. 2014;14:585–600.

doi: 10.1038/nri3707 pubmed: 25145755 pmcid: 4281037

Schwartz DM, Kanno Y, Villarino A, Ward M, Gadina M, O’Shea JJ. JAK inhibition as a therapeutic strategy for immune and inflammatory diseases. Nat Rev Drug Discov. 2017;16:843–62.

doi: 10.1038/nrd.2017.201 pubmed: 29104284

Leipe J, Grunke M, Dechant C, Reindl C, Kerzendorf U, Schulze-Koops H, et al. Role of Th17 cells in human autoimmune arthritis. Arthritis Rheumatism. 2010;62:2876–85.

doi: 10.1002/art.27622 pubmed: 20583102

Nakae S, Nambu A, Sudo K, Iwakura Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol. 2003;171:6173–7.

doi: 10.4049/jimmunol.171.11.6173 pubmed: 14634133

Lubberts E, Koenders MI, Oppers-Walgreen B, van den Bersselaar L, Coenen-de Roo CJ, Joosten LA, et al. Treatment with a neutralizing anti‐murine interleukin‐17 antibody after the onset of collagen‐induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheumatism. 2004;50:650–9.

doi: 10.1002/art.20001 pubmed: 14872510

Yasuda K, Takeuchi Y, Hirota K. The pathogenicity of Th17 cells in autoimmune diseases. Semin Immunopathol. 2019;41:283–97. https://doi.org/10.1007/s00281-019-00733-8

doi: 10.1007/s00281-019-00733-8 pubmed: 30891627

Wu B, Zhang S, Guo Z, Bi Y, Zhou M, Li P, et al. The TGF-β superfamily cytokine Activin-A is induced during autoimmune neuroinflammation and drives pathogenic Th17 cell differentiation. Immunity. 2021;54:308–323.e306. https://doi.org/10.1016/j.immuni.2020.12.010

doi: 10.1016/j.immuni.2020.12.010 pubmed: 33421362 pmcid: 7878438

Li P, Guo Z, Wan YY. SKI expression suppresses pathogenic Th17 cell response and mitigates experimental autoimmune encephalomyelitis. Front Immunol. 2021;12:707899. https://doi.org/10.3389/fimmu.2021.707899

doi: 10.3389/fimmu.2021.707899 pubmed: 34335622 pmcid: 8321777

Choi G, Park YJ, Cho M, Moon H, Kim D, Kang CY, et al. A critical role for Th17 cell-derived TGF-β1 in regulating the stability and pathogenicity of autoimmune Th17 cells. Exp Mol Med. 2021;53:993–1004. https://doi.org/10.1038/s12276-021-00632-9

doi: 10.1038/s12276-021-00632-9 pubmed: 34050263 pmcid: 8178381

Das J, Ren G, Zhang L, Roberts AI, Zhao X, Bothwell AL, et al. Transforming growth factor β is dispensable for the molecular orchestration of Th17 cell differentiation. J Exp Med. 2009;206:2407–16. https://doi.org/10.1084/jem.20082286

doi: 10.1084/jem.20082286 pubmed: 19808254 pmcid: 2768861

Xu L, Kitani A, Fuss I, Strober W. Cutting edge: regulatory T cells induce CD4 + CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J Immunol. 2007;178:6725–9. https://doi.org/10.4049/jimmunol.178.11.6725

doi: 10.4049/jimmunol.178.11.6725 pubmed: 17513718

Noack M, Miossec P. Th17 and regulatory T cell balance in autoimmune and inflammatory diseases. Autoimmun Rev. 2014;13:668–77. https://doi.org/10.1016/j.autrev.2013.12.004

doi: 10.1016/j.autrev.2013.12.004 pubmed: 24418308

Zhou X, Bailey-Bucktrout SL, Jeker LT, Penaranda C, Martínez-Llordella M, Ashby M, et al. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol. 2009;10:1000–7. https://doi.org/10.1038/ni.1774

doi: 10.1038/ni.1774 pubmed: 19633673 pmcid: 2729804

Komatsu N, Okamoto K, Sawa S, Nakashima T, Oh-hora M, Kodama T, et al. Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis. Nat Med. 2014;20:62–68. https://doi.org/10.1038/nm.3432

doi: 10.1038/nm.3432 pubmed: 24362934

Huber S, Stahl FR, Schrader J, Lüth S, Presser K, Carambia A, et al. Activin a promotes the TGF-beta-induced conversion of CD4 + CD25- T cells into Foxp3+ induced regulatory T cells. J Immunol. 2009;182:4633–40. https://doi.org/10.4049/jimmunol.0803143

doi: 10.4049/jimmunol.0803143 pubmed: 19342638

Annes JP, Munger JS, Rifkin DB. Making sense of latent TGFβ activation. J Cell Sci. 2003;116:217–24.

doi: 10.1242/jcs.00229 pubmed: 12482908

Lawrence DA. Latent-TGF-β: an overview. Mol Cell Biochem. 2001;219:163–70.

doi: 10.1023/A:1010819716023 pubmed: 11354248

Intricacies of TGF-β signaling in Treg and Th17 cell biology.

Journal

Informations de publication

Résumé

Identifiants

Substances chimiques

Types de publication

Langues

Sous-ensembles de citation

Pagination

Subventions

Informations de copyright

Références

Auteurs

Junying Wang (J)

Xingqi Zhao (X)

Yisong Y Wan (YY)

Articles similaires

Spatial multiplex analysis of lung cancer reveals that regulatory T cells attenuate KRAS-G12C inhibitor-induced immune responses.

The FGF/FGFR/c-Myc axis as a promising therapeutic target in multiple myeloma.

Exploring transcriptomic mechanisms underlying pulmonary adaptation to diverse environments in Indian rams.

Calcineurin inhibition enhances

Classifications MeSH